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Résumé 
La schizophrénie est une psychopathologie largement hétérogène caractérisée 
entre autres par d’importantes défaillances dans le fonctionnement cognitif et 
émotionnel. En effet, par rapport à la population générale, forte proportion de ces 
individus présentent une mémoire déficitaire pour les événements émotionnels. À ce 
jour, le peu d’études qui se sont penchées sur la mémoire émotionnelle épisodique 
dans la schizophrénie, ont uniquement mis l’emphase sur l'effet de la valence des 
stimuli (c’est-à-dire le caractère agréable ou désagréable du stimulus). Toutefois, 
aucune n’a investigué spécifiquement l’intensité de la réaction aux stimuli (c’est-à-dire 
une faible par rapport à une forte réaction) malgré quantité de preuves faisant montre, 
dans la population générale, de différents processus de mémoire émotionnelle pour des 
stimuli suscitant une forte réaction par rapport à ceux évoquant une faible réponse. Ce 
manque est d’autant plus flagrant étant donné le nombre d’études ayant rapporté un 
traitement et un encodage atypiques des émotions spécifiquement au niveau de 
l’intensité de la réponse subjective chez des patients atteints de schizophrénie. Autre 
fait important, il est étonnant de constater l’absence de recherches sur les différences 
de sexe dans la mémoire émotionnelle étant donné l’ensemble des divergences entre 
hommes et femmes atteints de schizophrénie au niveau de la prévalence, de l’âge de 
diagnostic, de la manifestation clinique, de l’évolution de la maladie, de la réponse au 
traitement et des structures cérébrales. Pour pallier à ces lacunes, ce mémoire a 
évalué : (1) l’effet de la valence des stimuli et de l'intensité de la réaction émotionnelle 
au niveau des fonctions cérébrales correspondant à la mémoire émotionnelle chez des 
patients atteints de schizophrénie comparativement à des participants sains; et (2) les 
possibles différences de sexe dans les processus cérébraux impliqués dans la mémoire 
émotionnelle chez des patients atteints de schizophrénie par rapport à des volontaires 
sains. 
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Ainsi, la première étude a comparé les activations cérébrales de patients 
atteints de schizophrénie par rapport à des participants sains au cours d’une tâche de 
mémoire émotionnelle dont les stimuli variaient à la fois au niveau de la valence et de 
l'intensité de la réaction subjective. 37 patients atteints de schizophrénie ainsi que 37 
participants en bonne santé ont effectué cette tâche de mémoire émotionnelle lors 
d’une session d’imagerie par résonance magnétique fonctionnelle (IRMf). Pour toutes 
les conditions étudiées (images négatives, positives, de faible et de forte intensité), le 
groupe atteint de schizophrénie a performé significativement moins bien que les 
volontaires sains. Comparativement aux sujets sains, ils ont montré moins d’activations 
cérébrales dans les régions limbiques et préfrontales lors de la reconnaissance des 
images négatives, mais ont présenté un patron d'activations similaire à celui des 
participants sains lors de la reconnaissance des images chargées positivement 
(activations observées dans le cervelet, le cortex temporal et préfrontal). Enfin, 
indépendamment de la valence des stimuli, les deux groupes ont démontré une 
augmentation des activations cérébrales pour les images de forte intensité par rapport à 
celles de plus faible intensité. 
La seconde étude a quant à elle exploré les différences de sexe potentielles au 
niveau des activations cérébrales associées à la mémoire émotionnelle dans la 
schizophrénie et dans la population en général. Nous avons comparé 41 patients 
atteints de schizophrénie (20 femmes) à 41 participants en bonne santé (19 femmes) 
alors qu’ils effectuaient la même tâche de mémoire émotionnelle mentionnée plus haut. 
Or, pour cette étude, nous nous sommes concentrés sur les conditions suivantes : la 
reconnaissance d’images positives, négatives et neutres. Nous n'avons pas observé de 
différences entre les hommes et les femmes au niveau des performances à la tâche de 
mémoire pour aucune des conditions. En ce qui a trait aux données de neuroimagerie, 
comparativement aux femmes en bonne santé, celles atteintes de schizophrénie ont 
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montré une diminution des activations cérébrales dans les régions corticales du 
système limbique (p. ex. cortex cingulaire moyen) et dans les régions sous-corticales 
(p. ex. amygdale) lors de la reconnaissance d'images négatives. Pour ce qui est de la 
condition positive, elles ont présenté, comparativement au groupe de femmes saines, 
des diminutions d’activations spécifiquement dans le cervelet ainsi que dans le gyrus 
frontal inférieur et moyen. Les hommes atteints de schizophrénie, eux, ont montré une 
augmentation d’activations par rapport aux hommes sains dans le gyrus préfrontal 
médian lors de la reconnaissance des stimuli négatifs ; ainsi que dans les régions 
pariétales, temporales et limbiques lors de la reconnaissance des stimuli positifs. Dans 
un autre ordre d’idées, notre analyse corrélationnelle a mis en évidence, chez les 
femmes, un lien significatif entre l’activité cérébrale et les symptômes au cours de la 
mémoire des stimuli positifs, alors que chez les hommes atteints schizophrénie, ce lien 
a été observé au cours de la mémoire des stimuli négatifs. 
Bref, l’ensemble de nos résultats suggère, chez les patients atteints de 
schizophrénie, un fonctionnement cérébral atypique spécifiquement lors de la 
reconnaissance d’images négatives, mais un fonctionnement intact lors de la 
reconnaissance de stimuli positifs. De plus, nous avons mis en évidence la présence de 
différences de sexe dans les activations cérébrales associées à la mémoire épisodique 
émotionnelle soulignant ainsi l'importance d’étudier séparément les hommes et les 
femmes atteints de schizophrénie dans le cadre de recherches sur les plans cognitif et 
émotionnel.  
Mots-clés : Différences de sexe, mémoire émotionnelle, valence, intensité, 
schizophrénie, IRMf 
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Abstract 
Schizophrenia is characterized by prominent disturbances in cognitive and 
emotional functioning. For instance, individuals with schizophrenia are often impaired in 
their memory for emotional events compared to healthy subjects. To date, the limited 
research on emotional episodic memory in schizophrenia has focused on the effect of 
valence of affective stimuli (e.g., pleasant vs. unpleasant), while overall ignoring the 
effect of arousal (e.g., low vs. high) despite evidence of distinct emotional memory 
processes for high versus low arousing stimuli in the general population, as well as 
reports of abnormal processing of arousing stimuli in schizophrenia. What’s more, there 
has yet to be examination of sex differences in the behavioral and neural correlates of 
emotional memory in this complex psychiatric disorder, which is astonishing considering 
the substantial evidence of sex differences in almost all features of schizophrenia from 
prevalence, mean age at onset, clinical presentation, course of illness, response to 
treatment and brain structure. Accordingly, this thesis examined: (1) the effect of both 
affective valence and arousal intensity on the brain activations associated with 
emotional memory in patients with schizophrenia and in healthy control participants and 
(2) potential sex differences in brain function during emotional memory. 
The first study aimed to compare cerebral activations in patients with 
schizophrenia and healthy controls during memory retrieval of emotional images that 
varied in both valence and arousal. Using fMRI, 37 patients with schizophrenia (% male 
= 51; mean age =32.46) were compared to 37 healthy participants (% male = 51; mean 
age =31.81) while performing an emotional memory task.  patients with schizophrenia 
performed worse than healthy controls in all experimental conditions. They showed less 
cerebral activations in limbic and prefrontal regions than controls during retrieval of 
negatively valenced stimuli, but had a similar pattern of brain activations to controls 
during retrieval of positively valenced stimuli (particularly in the high arousal condition) 
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in the cerebellum, temporal and prefrontal cortex. Both groups demonstrated increased 
brain activations in the high relative to low arousing conditions.  
 The second study explored potential sex differences in the brain activations 
associated with the recognition of emotional images in schizophrenia and healthy 
controls. 41 patients with schizophrenia (20 women) were compared to 41 healthy 
participants (19 women) while performing a yes/no recognition paradigm with positive, 
negative and neutral images in an fMRI scan. We did not observe sex differences in 
performance. Compared to healthy women, women with schizophrenia showed a 
decrease in brain activations in cortical (e.g. middle cingulate) and subcortical limbic 
structures (e.g. amygdala) during recognition of negative images and decreased 
activations during the positive condition in the cerebellar vermis, middle and inferior 
frontal gyrus. Men with schizophrenia had increased activations compared to healthy 
men in the medial prefrontal gyrus during recognition of negative stimuli and a 
substantial increase in brain activity during the recognition of positive pictures in 
parietal, temporal and limbic structures. Correlation analysis revealed significant 
relationships between brain function and symptoms during positive emotional memory 
in women and during negative emotional memory primarily in men.  
 Taken as a whole, our results suggest atypical brain function during retrieval of 
negative pictures, but intact functional circuitry of positive affect during episodic memory 
retrieval in patients with schizophrenia compared to healthy subjects. Moreover, our 
findings revealed sex differences in the brain activations associated with emotional 
recognition memory in patients with schizophrenia; which further highlights the 
importance of investigating men and women with schizophrenia separately in the 
context of emotional and cognitive tasks.  
Keywords: Sex differences, emotional memory, valence, arousal, schizophrenia, fMRI 
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Introduction 
I. Schizophrenia: An overview 
Evolution of the concept of schizophrenia: Kraepelin-Bleuler-Schneider 
Kraepelin (1919), Bleuler (1911) and Schneider (1959) were instrumental figures 
in the conceptualization of schizophrenia, even though their different ideas led to 
inconsistencies in defining the illness over the past century (Hoenig, 1983). Kraepelin 
(1919) believed that schizophrenia comprised a unique disease entity with a single 
etiology and a distinct pathology. Because the cause was unknown, classification 
depended largely on the course and outcome of groups of symptoms. More specifically, 
Kraepelin noted a tendency towards deterioration and an outcome of mental dullness or 
dementia in patients with an adolescent or early adult onset of catatonia, hebephrenia, 
and paranoid dementia – a group he termed dementia praecox. 
The term schizophrenia, which literally means “a mind that is torn asunder”, was 
later coined by Euegen Bleuler (1911). In contrast to Kraepelin’s neurodegenerative 
disorder of adolescents, Bleuler defined a set of basic symptoms considered to be 
unique to the disorder and present in all patients with the disorder. Moreover, he 
considered course and outcome of the illness to be variable (e.g. stable outcome, 
improvement after onset). Rather than the essence of schizophrenia being defined by 
delusions and hallucinations, Bleuler believed that loosening of associations, blunted 
affect, ambivalence and autism (now considered negative symptoms) were the 
fundamental symptoms of the illness.  
Subsequently, Jaspers (1946) deemed that a deficit in compassionate 
interactions in individuals with schizophrenia and an “un-understandability” of the 
individual experience as significant features of the disorder. Building on this concept, 
Schneider (1959) defined the first-rank symptoms of schizophrenia (e.g. thoughts 
experienced as spoken aloud, voices making references in the third person), which 
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were thought by Schneider and others (Mellor, 1970) to be pathognomonic. However, 
with time this assertion was challenged in light of Schneiderian first-rank symptoms 
being present in a variety of other nonorganic psychotic psychiatric disorders (Janowsky 
& Risch, 1979; O'Grady, 1990).  
Clearly, these three viewpoints of describing this complex and heterogeneous 
psychiatric disorder are distinctive. The tools currently used to define schizophrenia 
including DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders) and ICD-
10 (International Classification of Diseases) criteria incorporate Kraepelinian chronicity, 
Bleulerian negative symptoms and Schneiderian positive symptoms. However, the use 
of different combinations and variable interpretations of these elements with restricted 
psychopathological validity has led to widespread criticisms (Poland et al., 1994). 
The epidemiology of schizophrenia 
 Over the years there have been major epidemiological findings in the 
occurrence of schizophrenia across populations, time and socio-demographic 
characteristics (Tandon et al., 2008). Schizophrenia manifests itself in less than 1% of 
individuals in a population at some point in their lives (Perala et al., 2007; Stilo & 
Murray, 2010). The most recent studies suggest that the rate of 1% could be an 
overestimation and that the prevalence of the disorder is typically higher in developed 
than in developing countries, and higher in migrant groups than in native-born 
populations (McGrath et al., 2008; Saha et al., 2005). Additionally, a higher prevalence 
of schizophrenia among lower as opposed to higher socio-economic classes within 
communities has been steadily reported over the past century (Tandon et al., 2008).  
 The incidence of schizophrenia, defined as the number of new cases for a given 
population per year, has shown prominent discrepancies among scientific studies. A 
concise overview of three related systematic reviews on the incidence, prevalence, and 
mortality associated with schizophrenia has reported that the median incidence of 
3	  
 
schizophrenia was 15.2/100,000 persons and that the central 80% of estimates varied 
greatly over a range of 7.7-43/100,000 persons (McGrath et al., 2008). Moreover, 
significant variations in the incidence of schizophrenia have been documented such that 
urbanicity, migration and male gender have been linked with an increased risk of 
developing the disorder (Saha et al., 2006). A relatively consistent description of 
schizophrenia has been documented over the last two centuries and its occurrence has 
been relatively stable despite changes in specific diagnostic criteria (Bleuler, 1950; 
Kraepelin, 1971).  However, the incidence rates of schizophrenia are suggested to have 
fluctuated over time with some studies proposing an increase in schizophrenia (Bray et 
al., 2006) and others implying a decrease in the incidence of schizophrenia with time 
(Woogh, 2001). It is likely that changes in the tools used to diagnose schizophrenia and 
the manner in which cases are detected makes these assumptions difficult to interpret 
(Kendell et al., 1993). 
The clinical features of schizophrenia 
Schizophrenia is presently defined by a diverse set of signs and symptoms that 
are broadly classified into positive, negative, cognitive, disorganization, mood and motor 
symptom dimensions; with differing degrees of psychopathological expression observed 
across patients and throughout the course of illness (Tandon et al., 2010). Positive 
symptoms include delusions, hallucinations and other reality distortions while negative 
symptoms encompass a blunting or loss of a range of affective functions such as a loss 
of motivation, lack of experiencing pleasure, avolition and blunted affect. The 
occurrence of all types of hallucinations is about 50% in those with the disorder and of 
this percentage, 50% encompass auditory hallucinations (Cutting, 1990). Delusions, on 
the other hand, are reported to occur at some stage during the course of schizophrenia 
in more than 90% of those with the diagnosis (Cutting, 2002). With regards to negative 
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symptoms, flattening of affect is observed in approximately 50 % of acute (Andreasen, 
1979) or chronic patients with schizophrenia (McCreadie, 1982).  
Studies have shown that negative symptoms are generally more stable than 
positive symptoms and are least likely to improve over the course of illness (Addington 
et al., 1991; Andreasen & Flaum, 1991). For instance, Arndt and colleagues (1995) 
observed that while both negative and positive symptoms were already prominent at the 
time of the patients’ first episode, during the follow-up period, the negative symptoms 
remained relatively stable while the positive symptoms declined. In addition, it has been 
suggested that negative symptoms are more closely linked to prognosis, in spite of the 
suffering that may be associated with psychotic symptoms (Fuller et al., 2002). Many 
studies have shown that the level of negative symptoms is significantly associated with 
a poor level of social functioning (Biehl et al., 1986; Breier et al., 1991; Fenton & 
McGlashan, 1992; Keefe et al., 1987); albeit others have observed similar relationships 
between high levels of positive symptoms and social functioning (Breier et al., 1991; 
Keefe et al., 1987). A surprisingly consistent pattern has emerged between impairments 
in cognitive ability and symptom profiles, such that cognitive impairment correlates with 
negative and disorganized symptoms (Andreasen, Flaum, et al., 1990; Bilder et al., 
1985; Braff, 1989; Keilp et al., 1988; Merriam et al., 1990) but not with psychotic 
symptoms in patients with schizophrenia (Bilder, et al., 1985; O'Leary et al., 2000).  
What causes schizophrenia? 
 Schizophrenia is a complex, incapacitating and heterogeneous psychiatric 
disorder, and to date the etiology of the illness remains a mystery. Even so, several 
theories on the origin of schizophrenia have been put forward.  
 The risk of developing schizophrenia increases considerably in an individual 
who has an affected family member, a risk that intensifies as the degree of genetic 
similarity with the affected family member increases (i.e. a first degree relative) (Kendler 
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& Diehl, 1993; Sullivan et al., 2003). Twin studies of schizophrenia show consistently 
higher concordance rates in monozygotic (around 50%) than in dizygotic twins (around 
17%) (Cardno and Gottesman, 2000). Correspondingly, both individual twin studies and 
meta-analyses of twin studies estimate the heritability of schizophrenia to be roughly 
80% (Riley and Kendler, 2006). Nonetheless, more than two thirds of individuals with 
schizophrenia do not present with a family history of the illness (Kendler et al., 1993) 
and no gene appears to be either sufficient or necessary for the development of 
schizophrenia (Tandon et al., 2008). Thus, the prevalent genetic opinion is that 
schizophrenia is a polygenic/multifactorial disease (Lichtermann et al., 2000). Other 
than genes, both pre- and perinatal complications (e.g. maternal influenza, fetal 
hypoxia) and other environmental elements (e.g. season of birth, cannabis use) have 
been linked to a substantial increase in the risk of developing the disorder (McGrath, 
2011; Mittal et al., 2008; Tandon, et al., 2008; van Os et al., 2008).  After decades of 
research what can be said with confidence is that both genetic and environmental 
elements are at play (Tandon et al., 2008).  
 It has been suggested that schizophrenia is "not the result of a discrete event or 
illness process at all, but rather one end of the developmental spectrum that for genetic 
and/or other reasons 0.5% of the population will fall into." (Weinberger, 1987). 
Developmental changes in the brain that span from the fetal period through young 
adulthood are now a vital feature of most etiological theories of schizophrenia and this 
neurodevelopmental hypothesis of schizophrenia is rarely challenged in the literature 
(Gourion et al., 2004; Walker et al., 2010; Weinberger, 1996). Simplified, the broad 
neurodevelopmental view of schizophrenia dictates that both genetic and prenatal 
factors confer vulnerability of schizophrenia by inducing pathologic processes beginning 
before the brain approaches its adult state in adolescence (Fatemi & Folsom, 2009; 
Rapoport et al., 2005). Developing in utero as early as late first or early second 
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trimester (Fatemi et al., 2005), these neurodevelopmental anomalies are proposed to 
lead to the activation of pathologic neural circuits during critical developmental time 
points in adolescence (sometimes due to elevated stress), ultimately guiding the 
manifestation of positive and/or negative symptoms (Fatemi & Folsom, 2009; Keshavan 
& Hogarty, 1999; Walker, et al., 2010). Yet, precisely how and in what way genetic and 
environmental factors might interact to cause schizophrenia and the neurobiological 
mechanism that may mediate such interactions remains unknown. 
Treatment without a cure  
 As far as we know, there is no cure for schizophrenia. In spite of this, existing 
multi-modal regimens that embrace the use of antipsychotic medications, psychosocial 
interventions, as well as support with housing and financial sustenance are accessible 
to individuals with schizophrenia (Tandon, et al., 2010).  
About half a century ago, antipsychotic drugs were established into clinical 
practice sparking the revolution in the pharmacotherapy of schizophrenia (Delay et al., 
1952). First generation antipsychotic drugs (i.e. typical antipsychotic) have been shown 
to be effective in relieving the positive symptoms of schizophrenia and in preventing 
their reappearance in several patients (for a review see Miyamoto et al., 2005), while 
having little therapeutic effects on negative symptoms, mood symptoms and cognitive 
deficits (Fleischhacker, 1995; Hawkins et al., 1999; Tandon et al., 2009). Instead, 
second-generation or atypical antipsychotic drugs such as clozapine are reported to 
have superior therapeutic benefits for cognitive and negative symptoms (Keefe et al., 
1999; Meltzer & McGurk, 1999); a conjecture that is today continuously debated (Faber 
et al., 2011; Keefe et al., 2007; Remington & Kapur, 2000). Interestingly, several recent 
studies appear to imply that atypical antipsychotic agents are no more effective than 
typical drugs and are not associated with better cognitive or social outcomes (Jones et 
al., 2006; Keefe, et al., 2007; Lieberman et al., 2005; Swartz et al., 2007). While typical 
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antipsychotics cause a range of side effects such as acute extrapyramidal symptoms 
and tardive dyskinesia (Miyamoto et al., 2002; Tandon, et al., 2010) the atypical agents 
produce other serious side effects including agranulocytosis, weight gain and diabetes 
(Lieberman & Safferman, 1992; McIntyre et al., 2001; Melkersson & Dahl, 2004). 
Regardless, the finding that atypical drugs increase efficacy in treatment refractory 
patients (Essali et al., 2010; McEvoy et al., 2006) and lower the risk of extrapyramidal 
symptoms (Pierre, 2005) have given the scientific community hope that a superior 
antipsychotic treatment for individuals with schizophrenia is achievable (Tandon et al., 
2010). No matter the type of drug used, antipsychotic medications are consistently 
reported to be superior to placebos in reducing overall symptom severity and the risk of 
relapse in patients with schizophrenia (Leucht et al., 2003). It is noteworthy to keep in 
mind; however, that despite the reported therapeutic benefits of antipsychotic 
medications, the extent to which their use impacts the mortality, social functioning and 
overall quality of life in patients with schizophrenia are less clear and research on this 
topic has yielded inconsistent findings (Lehman et al., 2004; Ren et al., 2009; Thirthalli 
et al., 2010; Weinmann et al., 2009). 
As stated by Fenton and Schooler (2000) “patients are more than the sum of 
their symptoms”. These authors emphasize that the management of this disabling 
psychiatric disorder extends beyond the use of antipsychotic drugs. The literature has 
yielded cumulative evidence of the efficacy of various psychosocial interventions such 
as psychoeducation (Giron et al., 2010; Pitschel-Walz et al., 2001), Cognitive Behavior 
Therapy (Gould et al., 2001; Zimmermann et al., 2005), Social Skills Training (Kurtz & 
Mueser, 2008), Assertive Community Treatment (Nelson et al., 2007) and Cognitive 
Remediation approaches (McGurk et al., 2007) on various symptom domains, albeit not 
all studies have found these therapies to be useful (Tandon et al., 2010). The potential 
benefit of using psychosocial therapies as adjuncts to pharmacotherapy in alleviating 
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certain symptoms, improving compliance to medication, social functioning and quality of 
life in individuals with schizophrenia is particularly important in light of evidence that 
30% of individuals with the disorder are resistant to the classical antipsychotic drugs 
used today (Meltzer, 1997). 
Outcome – what are the consequences of schizophrenia?  
Many studies have examined the outcome or “consequences” of schizophrenia. 
Still, the data on longitudinal outcome have consistently run into tribulations concerning 
definitions of sample and measures used to assess outcome, among many other 
confounds and biases, making comparison between studies complicated (Allardyce & 
van Os, 2010).  
The consequences of Kraepelin’s schizophrenia were depicted as 
encompassing a permanent and pervasive impairment in mental functions – an 
inexorably deteriorating disorder (Kraepelin, 1919). Subsequently; however, he 
acknowledged that recovery was possible in dementia praecox (Kraepelin, 1920); a 
premise that has been reinforced by a growing body of research in which varying 
degrees of recovery have been observed in patients with schizophrenia. A systematic 
review of prospective studies analyzing first-episode psychosis published between 1966 
and 2003 have outlined a superior outcome for 42% of the population, an intermediate 
outcome for 35%, and a poor outcome for 27% (Menezes et al., 2006). These authors 
also established a relationship between a developing country of origin with good 
outcome and the use of typical antipsychotic medication (versus atypical or a 
combination of both) and being treatment-naive at study entry with poor outcome. This 
review corresponds somewhat to other studies that have reported different degrees of 
partial or full recovery in individuals with the disorder as well as cases in which the 
illness has resolved completely or ended in a severe defect state (Harrison et al., 2001; 
Hegarty et al., 1994; Jobe & Harrow, 2005). 
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Outcome, in the framework of schizophrenia, is a multi-faceted concept 
encompassing several distinct areas of psychopathology, social functioning, quality of 
life and societal impact (Tandon et al., 2008). For instance, individuals with 
schizophrenia show an increased prevalence of comorbid psychiatric and medical 
illnesses (e.g. substance abuse, cardiovascular disease) (Bermanzohn et al., 2000; 
Leucht et al., 2007), have a decreased probability of employment and substantial 
impairments in quality of life (Eack & Newhill, 2007; Folsom et al., 2005) as well as an 
increased risk of suicide and death (Fenton, 2000; Palmer et al., 2005; Saha et al., 
2007; Seeman, 2007). Given the disabling characteristics of schizophrenia, it is 
understandable that the illness has profound impacts on affected individuals and their 
loved ones. A revealing example is the observation that families of affected individuals 
report both a higher subjective and objective burden in concurrence with less support 
from social networks and professionals (Magliano et al., 2005).  
At present, an acute illness onset, better premorbid functioning, improved 
cognitive abilities, absence of substance abuse, female sex and a later age of onset are 
associated with a superior outcome in patients with schizophrenia (Breier, et al., 1991; 
Flyckt et al., 2006; Riecher-Rossler & Rossler, 1998; Shepherd et al., 1989). 
Summary 
Schizophrenia manifests itself in less than 1% of the population and is broadly 
defined by a diverse set of positive, negative, disorganization, mood and motor 
symptom dimensions. Although its etiology remains a mystery, both genetic and 
environmental elements are at play. To date, multi-modal treatments exist for 
individuals with schizophrenia that encompasses the use of antipsychotic medications 
and psychosocial interventions. The benefit in using psychosocial therapies as adjuncts 
to pharmacological treatment is advantageous since about one third of patients with 
schizophrenia are resistant to the classical antipsychotics used today. Finally, research 
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has documented diverse outcomes in patients with schizophrenia varying from superior 
to intermediate to poor.  
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II. Sex differences in schizophrenia 
Why is it crucial to investigate sex differences in schizophrenia? Most 
importantly, understanding sex differences in various clinical features of the disorder 
such as its clinical expression, course of illness and response to treatment will not only 
provide an opportunity to broaden our understanding of the complex inner workings of 
this psychiatric disorder but may also provide a unique opportunity to delineate more 
appropriate treatment regimens based on sex. Considering the vast growth of this field 
in the past century, this thesis focuses on some of the most prominent areas of sex 
differences in schizophrenia.  
Epidemiology 
The incidence of schizophrenia is generally higher in men than women. A 
systematic review of 158 studies reported a median male:female rate ratio of 1.40 
(McGrath et al., 2004). In addition, ratio estimates from various different types of studies 
(e.g. methodologically rigorous studies, those before 1980, those using DSM-III criteria) 
lie between 1.27 and 1.54 and significantly exceed 1 highlighting an increased 
incidence of schizophrenia in men versus women (Abel et al., 2010). In the midst of 
studies that have found significant sex differences in favor of males, some have found 
the opposite pattern or no significant sex difference in incidence rates (Al Mousawi & 
Dunstan, 1998; Hambrecht et al., 1994; Jablenksy, 1992). Of interest, the different 
criteria used to diagnose schizophrenia over the years has affected the incidence rates 
among men and women. Lewine and colleagues (1984) found that the stricter the 
diagnostic criteria used, the more men than women were diagnosed with schizophrenia. 
For instance, schizophrenia was only diagnosable before the age of 45 according to 
DSM-III criteria, which lead to a greater exclusion of women and resulting in a higher 
proportion of men being diagnosed (Castle et al., 1993).  
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In contrast to the incidence data, studies have more or less consistently reported 
a lack of sex differences in prevalence rates (McGrath, et al., 2008; Perala, et al., 2007; 
Saha, et al., 2005). This has been found to be the case for various prevalence 
measures including combined point, period and lifetime prevalence estimates (Saha et 
al., 2005). To date it is unclear how to resolve the paradox of a robust sex difference in 
the incidence but lack of sex difference in prevalence of schizophrenia (Abel et al., 
2010).  
Age of onset 
An earlier age of onset in men compared to women with schizophrenia is 
perhaps one of the most robust findings of sex differences in schizophrenia (Review by 
Leung & Chue, 2000; Salem & Kring, 1998). Hafner et al. (Hafner, an der Heiden, et al., 
1998; Hafner, Maurer, et al., 1998) reported a peak of onset in men between the ages 
of 15-25 followed by a stable decline, while women have a broader peak between the 
ages of 15-30 with a second smaller peak between 45-49 years of age.  The consistent 
finding of an earlier age of onset in men of about 3-5 years has been shown to exist 
regardless of culture (Hambrecht et al., 1992; Lewine, 1981), definition of onset (Hafner 
et al., 1989; Hafner et al., 1993) and definition of illness (Hafner et al., 1989; Lewine et 
al., 1981). Nonetheless, there exist factors that have contributed to the elimination of 
sex differences in age of onset. Similar to the sex difference in incidence rates, when 
DSM-III criteria with an age of onset limit of 45 imposed, the sex difference dissipates 
(Shimizu & Kurachi, 1988). In addition, the sex difference in age of onset appears to 
apply to sporadic but not familial schizophrenia (Albus et al., 1994; DeLisi et al., 1994; 
Gorwood et al., 1995). In fact, of the factors associated with elimination of sex 
differences in age of onset, a positive family history is the most reliable finding (Leung 
and Chue, 2000).  
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Premorbid history 
 A number of reports have documented poorer premorbid functioning in male 
than female patients on a variety of domains. More specifically, before developing 
schizophrenia, men are more socially isolated and withdrawn, are less able to maintain 
friendships and sexual relationships, have lower levels of school and work function (e.g. 
worse academic performance and higher frequency of job changes) compared to pre-
schizophrenic women (Castle, et al., 1993; Childers & Harding, 1990; Crow et al., 1995; 
Goldstein et al., 1989; Larsen et al., 1996; Salem & Kring, 1998). Moreover, pre-women 
with schizophrenia are more than twice as likely to be married at the time of first 
hospitalization compared to pre-schizophrenia men (Hafner et al., 1989). Certain 
behaviors in childhood that precede the development of schizophrenia may be different 
in the sexes. For instance, male pre-schizophrenic children are inclined to demonstrate 
more externalizing behaviors (e.g. disruptive, agitated) while female pre-schizophrenic 
children show more internalizing behaviors (e.g. passive and avoidant) (Crow, et al., 
1995; Done et al., 1994; Watt, 1978). Sex differences in premorbid IQ have also been 
reported with more pervasive premorbid IQ deficits found in men compared to women, a 
finding that has correlated significantly with an earlier age of onset in men (Aylward et 
al., 1984). It is suggested that enhanced premorbid functioning in women is attributed to 
their later onset allowing them to complete their education, form personal relationships, 
marry and work before the illness takes over (Leung and Chue, 2000). 
Birth and family history 
In both male and female patients, obstetric complications have been linked to an 
earlier age of onset of schizophrenia, a poorer course of illness and ventricular 
enlargement (Foerster et al., 1991; Heun & Maier, 1993; O'Callaghan et al., 1992; 
Owen et al., 1988). To date, the evidence of sex differences in obstetric complications is 
contradictory. Some have documented that mothers of female patients suffer a higher 
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rate of obstetric complications (Verdoux & Bourgeois, 1993), others have reported the 
opposite (i.e. greater incidence in mothers of male patients) (Cantor-Graae et al., 1994; 
O'Callaghan, et al., 1992) or have not found considerable sex differences (Heun & 
Maier, 1993; Hultman et al., 1997). Several studies found an association between 
prenatal exposure to influenza in the second trimester and the later development of 
schizophrenia particularly in females, while others found this relationship to be equal 
between men and women (Adams et al., 1993; Takei et al., 1994; van Os & Selten, 
1998). Methodological issues such as small sample size and variable measures of 
selecting and weighting obstetric complications, among other variables, are suggested 
to play a role in these inconsistent findings (McNeil, 1995). Interestingly, individuals 
born in the winter and early spring months have about a 10% increased risk for 
developing schizophrenia (Schwartz, 2011). While some have found sex differences 
favoring both males and females in this season-of-birth effect (Chen et al., 1996; Pulver 
et al., 1992), this has not always been the case (Bradbury & Miller, 1985). 
According to several family studies and family history studies, relatives of 
women with schizophrenia have a greater risk of developing the disorder as well as a 
higher chance of developing schizoaffective and schizophreniform illness than the 
family members of men with schizophrenia (Leung and Chue, 2000). For instance, 
Sham et al. (1994) found a lifetime risk estimate of schizophrenia to be 20.6% in the 
first-degree relatives of female probands and 4% in those of male probands. However, 
some population-based register studies have uncovered equal familial risk in the sexes 
(Cannon et al., 1998; Kendler & Walsh, 1995). 
Clinical expression 
In general, men with schizophrenia show evidence of more negative symptoms 
such as social withdrawal, blunted affect, lack of motivation and poverty of speech (Kay 
et al., 1986; Ring et al., 1991; Schultz et al., 1997) while women exhibit more affective 
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symptoms including depression, impulsivity, inappropriate affect, sexually inappropriate 
behavior and sexual delusions (Andia et al., 1995; Gur et al., 1996; Rector & Seeman, 
1992). Other than being characterized by a strong affective component, women with 
schizophrenia are over-represented among patients with schizoaffectIve disorder and 
more commonly have a differential diagnosis of bipolar or affective disorder 
(Bardenstein & McGlashan, 1990). Sex differences in the clinical expression of 
schizophrenia have been reported as being overall consistent in different countries and 
cultures (Goldstein, 1997; Hambrecht, et al., 1992; Jablenksy, 1992). Nevertheless, 
there have been disputes regarding whether males are characterized by more negative 
symptoms and females by more positive symptoms, although many agree that both 
sexes experience the same level of positive symptoms (Addington et al., 1996; Kendler 
& Walsh, 1995; Linstrom & Von Knorring, 1994). Still, specific positive symptoms such 
as paranoia, persecutory delusions and auditory hallucinations have been found to be 
higher in women than men with schizophrenia (Goldstein, 1997; Goldstein & Link, 1988; 
Hambrecht, et al., 1992; Marneros, 1984; Rector & Seeman, 1992; Tien, 1991). 
Interestingly, age has differentially contributed to the clinical expression of 
schizophrenia in men and women. For instance, Gur et al. (1996) observed that women 
continue to show less negative symptoms than men until the eighth decade of life, but 
have the same degree of positive symptoms across all age groups. In a sample of older 
patients with schizophrenia, Lindamer et al. (1999) found a greater severity of positive 
symptoms in men than women in the older age group and reported that women with a 
late onset exhibited less severe negative symptoms in comparison to men with late 
onset, and relative to both men and women with early onset. Complementing this 
finding, others have noted a significant association between older age at onset and 
fewer negative and cognitive symptoms among women with schizophrenia (Grossman 
et al., 2008; Morgan et al., 2008).  
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Course of illness 
 More often than not, women with schizophrenia have a better prognosis than 
men on several different areas. However, while this sex difference is prominent in the 
short- (2-5 years) and middle-term (5-10 years) (Goldstein, 1988; Goldstein, et al., 
1989; Salokangas & Stengard, 1990), this difference has been found to dissipate with 
time (i.e. in the long term; 13-40 years) (Gureje & Bamidele, 1998; Kendler & Walsh, 
1995; Nyman, 1989). In a major review of over 100 outcome studies, Angermeyer et al. 
(1990) found that in approximately half of the studies women showed a better course of 
hospital treatment, experienced a shorter length of hospital stay, and survived longer in 
the community after their first hospital admission while the other half of studies did not 
observe significant sex differences in the course of schizophrenia. Other domains in 
which women show a more favorable prognosis than men include education, 
occupational functioning, social functioning (e.g. higher rates of marriage and having 
children), less substance abuse and less antisocial behavior (Hafner, 2003; Leung & 
Chue, 2000). It is of interest that the degree of psychopathology is an outcome measure 
that does not seem to be different between the sexes (Hafner, et al., 1993; Shtasel et 
al., 1992). In any case, superior social and occupational functioning in women 
compared to men has been reported despite similar severity in symptom profiles (Andia, 
et al., 1995; Goldstein et al., 1989). It is suggested that worse outcomes in men may be 
associated to substance abuse which is more common in men than women with 
schizophrenia (Abel et al., 2010; Leung and Chue, 2000), particularly since patients with 
a dual diagnosis are less responsive to antipsychotic medication, less compliant with 
taking medication and are more frequently hospitalized and homeless (DeQuardo et al., 
1994; Dixon, 1999).  
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Response to treatment  
 Men and women with schizophrenia differ in their response to treatment at both 
the pharmacological and psychosocial level. Women with schizophrenia have been 
found to respond more quickly and show a greater degree of improvement on 
antipsychotic medications in comparison to men (Angermeyer, et al., 1990; Robinson et 
al., 1999; Szymanski et al., 1995; Usall et al., 2007). Usall and colleagues (2007) found 
that women with schizophrenia treated with both typical and atypical agents show 
significantly greater improvement in overall symptom severity compared with men. 
Moreover, women seem to require lower doses of first generation antipsychotics 
(Hogarty, Goldberg, & Schooler, 1974; Hogarty, Goldberg, Schooler, et al., 1974) until 
the age of 40 or post-menopause when the opposite pattern has been reported (i.e. 
women necessitate higher antipsychotic doses than men) (Seeman, 1983; 1986). Of 
interest, because estrogen is argued to play a protective role in women with 
schizophrenia by shielding them from the worse effects of the illness (Huber et al., 
2004; Seeman & Lang, 1990) it is suggested that a decrease in estrogen levels after 
menopause possibly contributes to the higher doses required in women (Leung and 
Chue, 2000). Others have not documented sex-specific differences in dosage or 
response to antipsychotics (Magharious et al., 1998; Pinals et al., 1996). Few studies 
have examined sex differences in response to atypical antipsychotics and the results 
have been mixed. Superior cognitive improvement in female compared to male patients 
taking olanzapine, risperidone and clozapine has been documented (Howard et al., 
2001) while some have noted no difference in men and women’s response (Perry et al., 
1991) or observed that female sex was a predictor of poor treatment response to 
second generation antipsychotic drugs (Lieberman et al., 1994; Szymanski et al., 1996). 
Female patients are more prone to certain side effects of clozapine (e.g. 
agranulocytosis, eosinophilia) than men (Alvir et al., 1993; Banov et al., 1993) and 
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generally experience adverse motor side effects on antipsychotics more frequently than 
men, with higher rates of parkinsonism, dystonia and tardive dyskinesia (Leung and 
Chue, 2000).  Sex differences in certain social behaviors have contributed to 
differences in the way men and women with schizophrenia respond to treatment. One 
pertinent example is the observation that men with schizophrenia are less likely to 
comply with antipsychotic medication than women (Tunnicliffe et al., 1992) but not all 
have observed this sex difference in behavior (Buchanan, 1992).  
 To date very few studies have investigated sex differences in response to 
psychosocial treatments in patients with schizophrenia. The findings point towards a 
pattern in which males appear to benefit to a greater degree from social skills training 
than women, but superior post treatment functioning in females (e.g. medication 
compliance) implies that factors other than taught skills are more important 
determinants of social adjustment in affected women (Schaub et al., 1998; Smith et al., 
1997).  
Cognition and Emotion 
 Evidence of sex differences in cognitive function in schizophrenia is mixed with 
some studies pointing to a superior performance by male patients, others reporting the 
opposite or no effect of sex on cognitive impairments in individuals with schizophrenia. 
Seidman and colleagues (1997) documented a worse performance in male compared to 
female patients on the Wisconsin Card Sorting Task known to assess executive 
function and working memory and indicative of dorsolateral prefrontal cortex deficits. 
Using an extensive battery of neuropsychological tests, Goldstein and colleagues 
(1998) found that men with schizophrenia were significantly impaired across all 
cognitive domains compared with same-sex control subjects and were impaired on tests 
of attention, verbal memory, and executive functions relative to women with 
schizophrenia. On the other hand, compared to healthy women, women with 
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schizophrenia had decreased performance on tests of attention, executive functions, 
visual memory, and motor functions suggesting that women with schizophrenia may be 
less vulnerable to deficits in verbal processing than schizophrenic men. In contrast to 
this pattern of results, Lewine et al. (1996) reported greater deficits on tasks of verbal 
and spatial memory as well as visual processing tasks in women compared to men with 
schizophrenia. In a more recent study women with schizophrenia performed better than 
men in processing speed and verbal episodic memory whereas men outperformed 
women in visual working memory (Torniainen et al., 2011). Finally, quite a few of 
studies have not found differences between men and women in cognitive performance 
(Albus et al., 1997; Andia, et al., 1995; Goldberg et al., 1995; Lewine et al., 2006; 
Shipman et al., 2009). However, some of these studies were confounded by differences 
in symptom expression, age at onset and medication highlighting the importance of 
taking these factors into careful consideration when evaluating potential sex differences. 
Noteworthy, significant relationships between impaired cognitive performance and 
social functioning have been particularly noted in women with schizophrenia, which is 
suggestive that cognitive deficits have greater adverse effects on social functioning in 
women than men (Mueser et al., 1995; Penn et al., 1996).  
Reports of sex differences in emotion processing in schizophrenia are few and 
far between in the scientific literature. Those that have analyzed men and women with 
schizophrenia separately found that women with schizophrenia are more expressive 
than men (Levin et al., 1985; Tremeau et al., 2005) while others have found no 
difference between the sexes (Davison et al., 1996). With respect to the experience of 
emotion, Heerey and Gold (2007) reported that women rate positive and negative 
images as being more pleasant and unpleasant, respectively, than did men with 
schizophrenia. In a study aimed at examining how individuals with schizophrenia 
respond to pleasant and unpleasant odors, men with schizophrenia rated the odors as 
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less pleasant than women with schizophrenia (Moberg et al., 2003) while a similar study 
found no difference between men and women in the pleasantness ratings of odors 
(Hudry et al., 2002). With regards to the recognition of emotions, Scholten et al. (2005) 
observed a sex difference in the ability to recognize facial emotions, especially negative 
ones, with women outperforming men. Vaskinn et al. (2007) and Weiss et al. (2007) 
reported similar findings such that women show a superior performance in recognizing 
facial emotions than men with the disorder.  
Brain structure 
 The tentative pattern of altered brain structure in patients with schizophrenia is 
that men are characterized by increased neuroanatomical deficits than their female 
counterparts. Still, other studies have reported the reverse pattern or no significant 
effect of sex on structural brain abnormalities in these individuals (Leung & Chue, 
2000). Methodological issues including small sample sizes, overrepresentation of men 
and variability in the size of brain structures of men and women in the healthy 
population are suggested to be at least partially responsible for the inconsistent results 
(Andreasen, Ehrhardt, et al., 1990; Goldstein, 1996).  
 Largely consistent with the direction of normal sexual dimorphism (Goldstein et 
al., 2001; Murphy et al., 1996; Paus et al., 1996), both structural neuroimaging and 
postmortem studies have reported that men with schizophrenia have enlarged 
ventricular-brain ratios and anterior temporal horn, smaller medial temporal lobe 
volumes (e.g. amygdala, hippcomapus, superior temporal gyrus) and overall smaller 
frontal and temporal lobe volumes compared to women with schizophrenia (For a 
review refer to Leung and Chue, 2000; Abel et al., 2010). Moreover, more left-
lateralized abnormalities have been reported in men (Goldstein et al., 2002; Gur, R. E. 
et al., 2000). It is noteworthy that some have uncovered region-specific structural 
abnormalities in women depending on the region examined. For instance, Goldstein 
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and colleagues (2002) reported a significant reduction in anterior cingulate volume in 
women with schizophrenia relative to healthy women while there was no difference 
between men with and without the diagnosis. Another study found that men with 
schizophrenia have a higher orbitofrontal to amygdala ratio than healthy men while 
women with schizophrenia have a lower ratio than healthy women (Gur et al., 2004). 
These findings are particularly interesting in the light of reports that in the general 
population it is women who have greater grey matter volume of anterior cingulate than 
men (Paus et al, 1996) and a higher orbitofrtonal cortex to amygdala ratio than men 
(Gur et al., 2002), ultimately implying a disturbance of normal sexual dimorphism of 
brain structure in individuals with schizophrenia.  
Brain function 
Although there is extensive evidence of sex differences in cerebral function 
associated with various emotional and cognitive tasks in the general population (e.g. 
Domes et al., 2010; Koch et al., 2007; Wager et al., 2003), evidence of sex differences 
in brain activations in individuals with schizophrenia is still quite scarce. This is not 
surprising considering the majority of studies investigating cerebral activations 
associated with emotional processing and cognitive function in schizophrenia consist 
almost exclusively of men, and even when women are included in the sample the 
number of tested individuals is typically too small to allow for between-sex comparisons.  
Previous work carried out by our group has uncovered distinct patterns of brain 
activations in men and women with schizophrenia during both cognitive (Guillem et al., 
2009; Jiménez et al., 2010) and emotional processing (Mendrek et al., 2007; 2009; 
2010). The overall findings point towards an alteration of the normal sexual dimorphism 
in cerebral activations in individuals with schizophrenia. For instance, Guillem et al. 
(2009) explored the differential effects of being male or female on the neural correlates 
of episodic memory in schizophrenia using event-related brain potentials (ERPs). They 
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uncovered that the direction of sex differences depended on the cognitive processes 
being examined. For instance, early frontal processes (related to interference inhibition) 
revealed an interaction between sex and diagnostic group suggesting a reversal of 
normal sexual dimorphism in their schizophrenia sample, while analysis of late posterior 
processes (suggested to reflect a mnemonic binding process) resulted in sex 
differences in the same direction in both patients with schizophrenia and healthy 
controls. Mendrek and colleagues (2007) implemented an fMRI task exploring the 
emotional experience of patients with schizophrenia and found that while viewing 
aversive pictures, men with schizophrenia exhibited more widespread and more intense 
activations compared to women with schizophrenia in similar brain regions where 
women would normally exhibit greater activations relative to men in the healthy 
population (e.g.cingulate gyrus, temporal cortex, cerebellum). Subsequent 
investigations revealed that the symptom profiles in men and women correlated 
differently with brain activations during processing of emotional information (Mendrek et 
al., 2010). Another recent study examined the recognition of emotional faces using 
ERPs and uncovered a lower P100 amplitude in the right hemisphere for fearful faces in 
men with schizophrenia compared to women which implies that sex can be an important 
controlling factor in early visual processing in patients with schizophrenia (Lee et al., 
2010). 
Summary 
 Sex differences in patients with schizophrenia exist in an array of domains 
including its epidemiology and clinical expression. Overall, men present with an earlier 
age of onset compared to women, women have more positive symptoms while men 
experience more negative symptoms, women with schizophrenia have a better 
prognosis, respond more quickly and show a greater degree of improvement with 
antipsychotic treatment relative to their male counterparts. However, the literature has 
23	  
 
illustrated inconsistencies in these findings; sex differences in cognitive function in 
schizophrenia have demonstrated particularly mixed results. To date, less research has 
focused on uncovering sex differences in response to psychosocial treatments, the 
processing of emotions and brain function in men and women with schizophrenia.  
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III. Emotional memory in schizophrenia 
It is well established in the scientific literature that individuals with schizophrenia 
have prominent deficits in cognition and the processing of emotional material (Heinrichs 
& Zakzanis, 1998; Kohler et al., 2000; Kohler & Martin, 2006; Rund & Borg, 1999). 
Investigating the effect of emotion on subsequent memory in individuals with 
schizophrenia provides a unique opportunity to examine the interaction between these 
two processes. This is particularly true in light of evidence that in the general population 
emotionally charged events often attain a privileged status in memory relative to neutral 
ones (Hamann, 2001; LaBar & Cabeza, 2006). What’s more, emotional memory 
paradigms appear more ecologically valid than encoding and/or retrieval of non-
emotional material, because in everyday life much of the information and events we 
come across holds emotional significance. In fact, it is relatively well accepted that 
emotion benefits cognition by prioritizing biologically relevant information (Damasio, 
1994). Nonetheless, investigating emotional episodic memory in individuals with 
schizophrenia is still limited.  
Behavioral findings 
 Behavioral evidence has outlined deficits in patients with schizophrenia 
compared to healthy controls on various dimensions associated with the processing of 
emotional memories. For instance, there is substantial evidence that patients with 
schizophrenia have impairments in independently initiating effective strategies during 
the encoding of stimuli into memory (Brebion et al., 1997; Iddon et al., 1998). 
Interestingly, when prompted to use encoding strategies, individuals with schizophrenia 
have shown significant improvement in mnemonic performance (e.g. Bonner-Jackson et 
al., 2005; Boyer et al., 2007; Koh & Peterson, 1978; Paul et al., 2005). However, some 
researchers who have directly compared incidental vs. intentional encoding have not 
found differences in memory performance in relation to diagnosis (Koh et al., 1976). In 
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general, the data has pointed towards a modest effect of intentional in comparison to 
incidental encoding on emotional memory performance in patients with schizophrenia 
(Herbener, 2008).  
Memory performance has also depended on the type of response used in the 
experimental paradigm. Tasks using recognition memory are suggested to selectively 
target memory processes while retrieval tasks entail a combination of both memory and 
executive abilities (Pelletier et al., 2005). A review by Heinrichs and Zakzanis (1998) 
reported that recall is typically more impaired in schizophrenia than recognition. 
Moreover, patients with schizophrenia demonstrate greater deficits in the recognition 
memory of visual (e.g. pictures) vs. verbal (e.g. words) stimuli (Pelletier et al., 2005). 
Consistent with this, a review of emotional memory studies in schizophrenia found that 
in all studies using pictorial stimuli, individuals with schizophrenia had an impaired 
memory in comparison to healthy control subjects (Herbener, 2008).  
Arousal and valence characteristics of emotional stimuli are factors that have 
also differentially influenced emotional memory in patients with schizophrenia and 
healthy subjects, though the results have been inconsistent. Some studies have found 
impairments in schizophrenia patient’s emotional memory compared to healthy subjects 
(Danion et al., 2003; Hall et al., 2007; Herbener et al., 2007; Neumann et al., 2007); 
while others have found comparable performances between the two groups (Horan et 
al., 2006; Koh, et al., 1976). Looking specifically at the effect emotional valence has on 
memory performance in patients with schizophrenia, some studies have demonstrated 
an enhancement of memory for emotional (both positive and negative) in contrast to 
neutral stimuli in patients with schizophrenia (Calev & Edelist, 1993; Hall, et al., 2007; 
Mathews & Barch, 2004), others have reported the opposite (i.e. neutral better 
remembered than emotional stimuli) (Koh et al., 1976; Mathews and Barch, 2004) or no 
effect of emotional stimuli on memory (Koh et al., 1981; Neumann, et al., 2007). 
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Furthermore, reports have documented increased memory for negative vs. positive 
stimuli in patients (Calev & Edilst, 1993; Herbener et al., 2007; Mathews & Barch, 2004) 
while few have reported the reverse pattern (Koh, et al., 1976).  Although the literature 
has presented conflicting results it has nonetheless outlined a tentative pattern in which 
individuals with schizophrenia more frequently show a lack of enhancement of 
emotional in contrast to neutral stimuli and also have a better memory for negative than 
positive stimuli (Herbener, 2008).  
The majority of the published studies have focused on the effect of emotional 
valence of presented stimuli (i.e. stimuli that vary from positive to negative), while the 
effect of arousal (i.e. stimuli that vary from calm to exciting) on memory performance 
has rarely been examined despite indications that it contributes significantly to memory 
in healthy individuals. Specifically, it has been found that highly arousing stimuli are 
better recalled than low arousing stimuli (Bradley et al., 1992; Eysenck, 1976).  Studies 
that have examined the effect of arousal on memory in patients with schizophrenia have 
outlined a better memory performance for stimuli of high emotional intensity relative to 
low intensity (Herbener et al., 2007; Horan et al., 2006; Mathews and Barch, 2004), but 
others have reported a detrimental effect of arousal on subsequent memory (Hall et al., 
2007).  
Despite research on emotional memory still being limited in schizophrenia, a few 
studies have noted a relationship between negative symptoms and impairments in 
emotional memory. Hall et al. (2007) uncovered a significant correlation between 
negative symptoms of the PANSS and recognition memory of both negative and neutral 
scenes such that the more negative symptoms the patients had the worse their 
recognition performance.  Another study investigated individual PANSS symptoms and 
reported that patients with greater blunted affect showed a greater impairment in the 
recall of high arousal negative and positive words. The authors also documented similar 
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relationships between blunted affect and recognition memory of all emotional conditions 
(i.e. high and low arousal). Horan and colleagues (2006) evaluated whether self-
reported trait anhedonia in schizophrenia reflects impaired memory for pleasant 
experiences but the authors did not find a significant association between these two 
measures despite schizophrenia patient’s elevated trait anhedonia.  
The variability in the emotional memory literature can easily be attributed to the 
differences in the stimuli used among studies (pictures vs. words), the type of retrieval 
method (recognition vs. recall), response type (old/new vs. remember/know), time of 
testing (delayed vs. immediate recall), as well as the clinical heterogeneity present in 
patients with schizophrenia. Accordingly, it is challenging to draw definite conclusions 
on the influence of emotion on memory in patients with schizophrenia.  
Neuroimaging findings 
To date, very few studies have examined the neural correlates of emotional 
memory in individuals with schizophrenia. Using fMRI, Whalley and colleagues (2009) 
reported robust medial temporal lobe activations in individuals with schizophrenia, 
individuals with bipolar disorder and healthy controls during viewing of positive scenes 
that correlated significantly with recognition memory of positive images. The direct 
group comparison revealed decreased activity in the bilateral amygdala in patients with 
schizophrenia relative to healthy participants in the cerebral activations associated with 
positive images versus baseline. This was found despite comparable recognition 
accuracies between the two groups. Another fMRI study using emotional faces found 
that patients with schizophrenia and healthy controls showed similar patterns of brain 
function associated with response bias for sad faces (e.g. parahippocampal gyrus) 
while response bias for happy faces revealed increased brain activations in healthy 
subjects compared to patients (e.g. superior frontal gyrus, amygdala and hippocampus) 
(Sergerie et al., 2010). Finally, Becerril and Barch (2011) explored how the emotional 
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valence of stimuli impacts the cerebral activations associated with an n-back working 
memory task and uncovered altered dorsolateral prefrontal cortex and hippocampus 
activity in individuals with schizophrenia while performing the emotionally loaded 
working memory task. 
Summary 
Deficits in patients with schizophrenia relative to healthy controls have been 
observed on various dimensions associated with the processing of emotional memories. 
Specifically, patients wit schizophrenia show impairments in initiating effective encoding 
strategies, they show greater deficits in recall than recognition, and have demonstrated 
differential deficits depending on whether the valence of the emotional stimuli was 
positive, negative or neutral. The effect of arousal intensity and the potential association 
of clinical symptoms on memory performance have been seldom examined. Functional 
neuroimaging studies investigating the neural correlates of emotional episodic memory 
in schizophrenia is slowly growing, while investigation of sex differences in this domain 
remains scarce.  
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IV. Hypotheses 
At present, there are no functional neuroimaging studies that have: (1) 
investigated the effect stimuli of different arousal intensities (i.e. calm vs. exciting) and 
valence (positive vs. negative) has on the pattern of brain function during emotional 
memory in schizophrenia patients compared to healthy controls and (2) have explored 
whether being male or female differentially contributes to the pattern of cerebral 
activations associated with the recognition memory of emotional images in patients with 
schizophrenia.  
Accordingly, the first goal of this thesis was to uncover the brain function 
associated with recognition memory of emotional stimuli that varied in both valence and 
arousal in patients with schizophrenia compared to healthy controls. In line with some 
behavioral studies of emotional memory (Danion et al., 2003; Mathews and Barch, 
2004; Neumann et al., 2007) and majority of neuroimaging studies of emotion 
processing in schizophrenia (Gur et al., 2002; Schneider et al., 1998; Takahashi et al., 
2004), we expected to observe a decreased recognition accuracy of emotional stimuli in 
patients with schizophrenia relative to healthy subjects and decreased cerebral 
activations in all experimental conditions (positive, negative, high and low arousal) in 
the medial temporal cortex as well as prefrontal regions previously implicated in 
emotion processing and memory (medial, middle frontal and orbitofrontal cortex) 
(Dolcos et al., 2004a, 2004b; LeDoux, 1993). In terms of the influence arousal has on 
memory for emotional stimuli, we expected to observe increased brain activations in the 
high relative to low arousal contrasts of the presented positive and negative stimuli in 
healthy controls.  In comparison, in patients with schizophrenia we expected an 
increase in activity only in the high arousal conditions based on evidence that patients, 
compared to healthy controls, are more likely to misidentify low arousal emotional 
stimuli as neutral (Kohler, et al., 2000), but recognize high intensity emotions without 
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difficulty (Hooker & Park, 2002). With regards to valence the literature has reported 
mixed results and consequently no predictions were made with regards to the effect of 
positive vs. negative emotion on subsequent memory in patients or controls. 
The second aim of this thesis was to explore sex-specific differences in the 
cerebral activations associated with emotional episodic memory in individuals with 
schizophrenia and healthy subjects. Our hypotheses were based on existing literature 
(Canli et al., 2002; Seidlitz & Diener, 1998) as well as previous results obtained by our 
group (Mendrek et al., 2010 ; Mendrek et al., 2007; Mendrek, 2009). Behaviorally, the 
cognitive-style hypothesis posits that men and women may differ in the way they 
encode, rehearse and think about emotional experiences that will ultimately lead to 
differences in performance (with women outperforming men; Seidlitz and Diener, 1998) 
and to qualitative differences in the pattern of cerebral activations during processing of 
emotional memories (Canli, et al., 2002; Piefke & Fink, 2005; Piefke et al., 2005). 
Accordingly, we predicted that patients with schizophrenia would be characterized by a 
decreased recognition accuracy compared to healthy subjects, but that women in both 
groups would have a superior recognition memory for emotional stimuli relative to men. 
With regards to cerebral functioning, we postulated that men and women in both groups 
would activate qualitatively distinct pattern of cerebral activations in regions previously 
implicated in emotion and episodic memory processes (e.g. regions of limbic and 
paralimbic cortex, parietal and prefrontal cortex) (Dolcos, et al., 2004a, 2004b; Hamann, 
2001; LaBar & Cabeza, 2006; Phan et al., 2004). In addition, based on existing findings 
(Mendrek, et al., 2010 ; Phillips et al., 2003; Phillips et al., 1999; Stip et al., 2005), we 
predicted significant correlations between negative symptoms and activations in cortical 
structures (e.g. prefrontal, cingulate cortex), and between positive symptoms and 
activations in subcortical limbic structures (e.g. amygdala, hippocampus). Moreover, 
because it has been documented that men with schizophrenia are typically more 
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affected by negative symptoms and women by positive symptoms (Leung and Chue, 
2000), we hypothesized that deficient brain activations during emotional memory in men 
would be mediated primarily by negative symptomatology, while positive symptoms 
would play a greater role in a distorted cerebral function in women.  
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Article 1 
The following article entitled “Neural correlates of emotional recognition memory in 
schizophrenia: effects of valence and arousal” was submitted to Psychiatry Research: 
Neuroimaging on May 2010 and was accepted for publication on May 2011 (see proof 
of acceptance). 
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Abstract:  
 
Schizophrenia patients are often impaired in their memory for emotional events 
compared to healthy subjects. Investigating the neural correlates of emotional memory 
in schizophrenia patients is scarce in the literature. The present study aimed to 
compare cerebral activations in schizophrenia patients and healthy controls during 
memory retrieval of emotional images that varied in both valence and arousal. Using 
fMRI, 37 schizophrenia patients were compared to 37 healthy participants while 
performing a yes/no recognition paradigm with positive, negative (differing in arousal 
intensity) and neutral images. Schizophrenia patients performed worse than healthy 
controls in all experimental conditions. They showed less cerebral activations in limbic 
and prefrontal regions than controls during retrieval of negatively valenced stimuli, but 
had a similar pattern of brain activations to controls during retrieval of positively 
valenced stimuli (particularly in the high arousal condition) in the cerebellum, temporal 
and prefrontal cortex. Both groups demonstrated increased brain activations in the high 
relative to low arousing conditions.  Our results suggest atypical brain function during 
retrieval of negative pictures, but intact functional circuitry of positive affect during 
episodic memory retrieval in schizophrenia patients. The arousal data revealed that 
schizophrenia patients closely resemble the control group at both the behavioral and 
neurofunctional level.  
 
Key words: fMRI, emotional memory, schizophrenia, valence, arousal 
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1. Introduction 
 
Deficits in cognition and emotional processing have become a hallmark of 
schizophrenia (Heinrichs and Zakzanis, 1998; Rund and Borg, 1999; Kohler et al., 
2000; Kohler and Martin, 2006). Investigating the effect of emotion on subsequent 
memory in individuals with schizophrenia provides a unique opportunity to examine the 
potential interaction between the two processes, particularly in light of evidence that in 
the general population emotionally charged stimuli are often better retained in memory 
than neutral stimuli (Hamann, 2001; LaBar and Cabeza, 2006). Furthermore, emotional 
memory paradigms appear more ecologically valid than encoding and/or retrieval of 
non-emotional material, because in everyday life much of the information and events we 
come across holds emotional significance.  
Investigating emotional memory in individuals with schizophrenia is still limited 
and shows mixed results. While some studies have found impairment in schizophrenia 
patient’s emotional memory compared to healthy subjects (Danion et al., 2003; Hall et 
al., 2007; Herbener et al., 2007; Neumann et al., 2007) others have found comparable 
performances between the two groups (Koh et al., 1976; Horan et al., 2006). With 
regards to the effect emotional valence has on memory performance in patients, some 
studies have demonstrated an enhancement of memory for emotional (both positive 
and negative) in contrast to neutral stimuli in schizophrenia patients (Hall et al., 2007; 
Mathews and Barch, 2004) others have reported the opposite (i.e. neutral better 
remembered than emotional stimuli) (Koh et al., 1976) or no effect of emotional stimuli 
on memory (Koh et al., 1981; Neumann et al., 2007). The majority of the published 
studies have focused on the effect of emotional valence of presented stimuli (i.e. stimuli 
that vary from positive to negative), while the effect of arousal (i.e. stimuli that vary from 
calm to exciting) on memory performance has rarely been examined despite indications 
that it contributes significantly to memory in healthy individuals. Specifically, it has been 
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found that highly arousing stimuli are better recalled than low arousing stimuli (Eysenck, 
1976; Bradley et al., 1992).  Studies investigating the effect of arousal on memory in 
patients with schizophrenia have outlined a better memory performance for stimuli of 
high emotional intensity relative to low intensity (Mathews and Barch, 2004; Horan et 
al., 2006; Herbener et al., 2007), but others have reported a detrimental effect of 
arousal on subsequent memory (Hall et al., 2007).  
Functional neuroimaging studies of emotional memory in healthy volunteers 
have reported activity in limbic regions including the amygdala, insula and cingulate 
cortex, as well as a range of areas in the temporal and prefrontal cortex, during 
recognition of items that were encoded in emotional relative to neutral contexts (e.g. 
Maratos et al., 2001; Smith et al., 2004). In patients with schizophrenia, studies of 
episodic memory (of neutral events) have demarcated a consistent and robust pattern 
of decreased cerebral activations in the prefrontal cortex, cerebellum and temporal lobe 
regions (for a meta-analysis see Achim and Lepage, 2005b). Increased cerebral 
activations have also been observed including hyperactivity of the hippocampus during 
both successful and unsuccessful mnemonic encoding (Zierhut et al., 2010) as well as a 
relative increase in activity in the cerebellum, visual and parietal cortex (Crespo-Facorro 
et al., 2001) during recognition memory in patients compared to healthy participants. 
Evidence of the neural correlates of emotional episodic memory in schizophrenia is 
limited in the literature. Whalley et al. (2009) reported robust medial temporal lobe 
activations in patients with bipolar disorder, patients with schizophrenia and healthy 
controls during memory encoding that correlated significantly with subsequent 
recognition memory performance. Nonetheless, there was no direct comparison 
between the schizophrenia and control group. Another fMRI study implemented an 
emotional memory paradigm with faces and reported emotion-specific differences in 
cerebral activations (e.g. hippocampus, parahippocampal and superior frontal gyrus) 
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associated with memory response bias in patients with schizophrenia and healthy 
subjects (Sergerie et al., 2010).  
The aim of the present study was to investigate the neural correlates associated 
with memory retrieval of stimuli that varied in both valence and arousal, in 
schizophrenia patients compared to healthy controls.   
In line with some behavioral studies of emotional memory (Danion et al., 2003; 
Mathews and Barch, 2004; Neumann et al., 2007) and majority of neuroimaging studies 
of emotion processing in schizophrenia outlining less sensitivity to emotional stimuli in 
patients relative to controls (Schneider et al., 1998; Gur et al., 2002; Takahashi et al., 
2004), we expected to observe a decreased recognition accuracy of emotional stimuli in 
schizophrenia patients relative to healthy subjects and decreased cerebral activations in 
all experimental conditions (positive, negative, high and low arousal) in medial temporal 
cortex, as well as prefrontal regions previously implicated in emotion processing and 
memory (medial, middle frontal and orbitofrontal cortex) (LeDoux, 1993; Dolcos et al., 
2004a; Dolcos et al., 2004b). In terms of the influence arousal has on memory for 
emotional stimuli, it has been found that relative to healthy controls, patients are more 
likely to misidentify low arousal emotional stimuli as neutral (Kohler et al., 2000), but 
recognize high intensity emotions without difficulty (Hooker and Park, 2002). Thus, we 
expected to observe increased brain activations in the high relative to low arousal 
contrasts of the presented positive and negative stimuli in healthy controls.  In 
comparison, in schizophrenia patients we did not expect to observe differences in brain 
activations elicited by memory of neutral and low arousing stimuli but did expect 
increased activity only in the high arousal conditions. Previous studies investigating the 
neural correlates of emotional arousal have observed activations in the anterior 
temporal pole, visual cortex, prefrontal cortex and regions of the medial temporal lobe in 
high relative to low arousing conditions (Lane et al., 1999; Bradley et al., 2003) (all 
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regions that have previously been implicated in functional neuroimaging studies of 
emotional memory as well). In this regard, we postulated that a similar pattern of 
regions would be activated in the high relative to low arousal contrasts in our emotional 
memory paradigm in both groups. With regards to valence the literature has reported 
mixed results, with some studies revealing different neural deficits underlying 
processing of positive and negative affect (Schneider et al., 1998; Gur et al., 2007; 
Reske et al., 2009), and others showing comparable brain activations during exposure 
to positive and negative stimuli in schizophrenia (Dowd and Barch, 2010). Behavioral 
studies of emotional memory have also yielded inconsistent results (Herbener, 2008). 
Consequently, no predictions were made with regards to the effect of positive vs. 
negative emotion on subsequent memory in patients or controls. 
2. Methods 
 
2.1. Subjects 
Thirty-seven schizophrenia patients (19 men, 18 women) meeting the DSM-IV 
criteria for schizophrenia (APA, 1994), in a stable phase of their illness (defined as no 
relapse within the last two months and no change in their antipsychotic treatment within 
the last month) and 37 healthy controls (19 men, 18 women) participated in the study.  
The groups were matched for age, sex, handedness (Edinburgh Inventory) (Oldfield, 
1971) and parental socio-economic status (National Occupational Classification; NOC) 
(Census, 2001) (Table 1).  
All patients were re-evaluated by experienced psychiatrists before being 
assigned to the research group (DSM-IV, criteria A-E); affective, schizoaffective and 
schizophreniform psychoses were excluded. Control participants were screened with 
the non-patients edition of the Clinical Interview for DSM-IV (SCID) (Spitzer et al., 
1992).  
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Symptom severity was rated according to the positive and negative syndrome scale 
(PANSS) (Kay et al., 1987).  Illness onset was defined as the date of the first psychiatric 
consultation. All the patients received at least one atypical antipsychotic (27 patients 
received one, 9 received two, 1 received three. Clozapine: n=19, mean dosage= 452.63 
mgs ± 77.23 mgs; olanzapine: n= 12, mean dosage= 14.58 mgs ± 5.4 mgs; risperidone: 
n=11, mean dosage= 3.73 ± 1.67 mgs; quetiapine: n=7, mean dosage= 585.71 mgs ± 
238.85 mgs).  
General exclusion criteria included age below 18 or above 45 years, past or 
present neurological or Axis-I psychiatric disorder, alcoholism or drug abuse, non 
compliance with testing procedures, abnormal uncorrected vision or any contra-
indication for MRI such as a cardiac pacemaker, an aneurysm clip, a metal prostheses 
or cardiac valve replacement, the presence of metal in an eye or any part of the body, 
certain dental work or claustrophobia. 
In agreement with the Declaration of Helsinki, written informed consent was 
obtained prior to participation in the experiment. The ability of schizophrenia patients to 
give informed consent was established using the guidelines of the Canadian Psychiatric 
Association. The study was approved by the ethics committees of the Fernand-Seguin 
Research Center of the Louis-H Lafontaine Hospital and the Regroupement 
Neuroimagerie Québec. 
2.2. Experimental procedure 
Prior to the memory task, participants passively viewed blocks of emotionally 
positive, negative, and neutral pictures while in the functional magnetic resonance 
imaging (fMRI) scanner. The stimuli were selected from the International Affective 
Picture System (IAPS) (Lang et al., 1988) based on normative valence and arousal 
ratings and were matched for content (e.g. people, animals, landscapes). The images 
differed in valence and arousal intensity resulting in 5 experimental conditions: High 
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arousal/positive content (HA+), High arousal/negative content (HA-), Low 
arousal/positive content (LA+), Low arousal/negative content (LA-) and neutral (NTR). 
Each image category was presented in separate blocks (i.e. one block contained only 
HA+ images, one contained only LA+ images, one contained only HA- images, etc.). It 
should be noted that although subjects were aware that a memory task would follow the 
emotion-processing run they were not explicitly told to try and remember the images. 
Instead, to ensure that participants were attentive to the presented images during 
encoding they were asked to indicate with the press of a button whether they saw a 
person or part of a person in the picture. In addition to allowing us to investigate 
cerebral responses to various affective stimuli, this task also served as an incidental 
learning procedure. This emotion processing task was then followed by an unrelated 
cognitive task with a duration of 15 minutes as a means of separating both incidental 
encoding and subsequent recognition memory.  
The memory portion consisted of viewing 48.5-second blocks of emotionally 
positive, negative, and neutral pictures similarly to the incidental encoding task. During 
this task, however, 50% of the stimuli in each block originated from the emotion-
processing task (previously viewed), while the other 50% were new (never before 
viewed). There were 16-second periods of rest separating the blocks from one another.  
Each block contained 10 images and each block was repeated 2 times (except NTR 
block which was repeated 4 times). Each picture appeared for 3000 ms followed by a 
blank screen with a fixation point for an average of 1.75 s (ranging from 1 to 2.5 s and 
giving an average inter-stimulus interval (ISI) of 4.75 s). During this memory task, 
participants’ were to determine, by pressing the correct button, which of the stimuli were 
old and which were new. To assess the participants subjective emotional responses to 
the presented images, immediately at the end of the fMRI session, participants were re-
presented with the images of each block and were asked to rate the block of images as 
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whole on a scale ranging from 0 (absence of any emotional reaction) to 8 (strongest 
emotion ever felt in one's lifetime) the intensity of experienced emotion for each block of 
stimuli. 
2.3. fMRI data acquisition  
Blood oxygenated dependent level (BOLD) signals were recorded using a 
single-shot, gradient-recalled echo-planar imaging sequence [repetition time (TR) = 
3000 ms, echo time (TE) = 30 ms, flip angle = 90 degrees, matrix 64 х 64 voxels] on a 
MRI Siemens TRIO system at 3.0 Tesla, which is operational at the Functional 
Neuroimaging Unit at the University of Montreal Geriatric Institute.  The functional 
volumes were then registered to individual high-resolution co-planar anatomical images 
taken during the same scanning session (three-dimensional, spoiled gradient echo 
sequence; 28 slices, slice thickness = 5 mm, TR = 22 ms, TE = 4 ms, flip angle = 30"; 
matrix 256 x 256 voxels) to better identify activated structures.  
2.4. fMRI data analysis 
The fMRI data was analyzed using statistical parametric mapping software 
(SPM5; Wellcome Department of Cognitive Neurology, London, UK) according to 
methods outlined by Friston and colleagues (Friston, 1995).  Functional images were 
realigned to the mean volume of each session to correct for artifacts due to subject 
motion, were spatially normalized into the standardized brain template (voxel size: 
3.5mm x 3.5mm x 3.5mm) and were spatially smoothed with a three-dimensional 
isotropic Gaussian kernel (12 mm FWHM) to improve the signal-to-noise ratio.   
Statistical analyses were carried out using a standard peak-detection approach 
and the general linear model implemented in SPM5 to identify the dynamic cerebral 
changes associated with emotional episodic memory.  First, fMRI data of each 
participant was analyzed using a fixed-effects model to investigate individual brain 
activation maps and to contrast the brain activity associated with different conditions. 
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The fixed-effects analysis produced individual contrast images that were then used as 
raw data for the implementation of a random-effects model to investigate the pattern of 
activations during the different emotional contrasts (HA-, LA-, HA+, LA+) in each group 
(i.e. healthy controls and schizophrenia patients). One-sample t-tests were conducted 
for each group to subtract brain activity associated with neutral from that associated 
with emotional stimuli (emotional minus neutral). Previous studies have documented 
increased autonomic responses as well as increased cerebral activations in 
schizophrenia patients relative to controls during the processing of neutral stimuli 
(Williams et al., 2004; Holt et al., 2006). To ensure that an increased response to 
neutral stimuli would not act to decrease the difference between responses to emotional 
and neutral images in schizophrenia patients relative to healthy controls we investigated 
the cerebral activations in the neutral relative to fixation conditions for both patients and 
controls. Considering the lack of studies investigating the neural correlates of emotional 
memory in schizophrenia, we performed an exploratory analysis for the entire brain 
volume. The threshold level for statistical significance was set at a p=0.001 corrected 
for multiple comparisons using the small volume correction (SVC) with the sphere 
volume function in SPM5 (radius = 16 mm). We also examined any potential differences 
between groups using a two-sample t-test with the threshold level for statistical 
significance at a p=0.005 uncorrected for multiple comparison. Only extent thresholds of 
5 contiguous voxels were considered. Effects at each voxel of the brain was estimated 
using the general linear model and voxel values for the contrasts of interest generated 
statistical parametric maps of the t statistic (SPM t) that were subsequently transformed 
to the unit normal distribution (SPM Z).  
2.5. Behavioral data analyses 
Recognition accuracy was measured by taking into account both the hit rate and 
false alarm rate. The hit rate is defined as the number of old slides correctly identified 
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as having been seen before divided by the total number of old slides and false alarm 
rate is characterized by the number of distractor slides incorrectly identified as seen 
before divided by the total number of distractor slides (Hall et al., 2007). The recognition 
accuracy was calculated as the difference between the hit and false alarm rate with a 
maximum value of +1 (perfect recognition of stimuli presented during incidental 
encoding) and a minimum value of -1 (falsely reporting that they had previously seen 
every new picture).  
To examine ratings of emotional stimuli and recognition accuracy we conducted 
a repeated measures ANOVA with image type (i.e. HA-, LA-, HA+, LA+ and NTR) as a 
within subject factor and diagnostic group (controls and schizophrenia patients) as a 
between subject factor. Where group or stimulus effects were detected the source of 
these effects was further investigated using post hoc t-tests. To account for an inflation 
of the type I error rate attributable to multiple post hoc testing, the threshold for 
significance was Bonferroni adjusted. 
 The demographic, clinical and behavioral data were analyzed with the Statistical 
Package for the Social Sciences (SPSS), version 15.0. 
3. Results 
 
3.1. Behavioral data 
 
3.1.1. Stimulus ratings  
 
The analysis revealed a significant main effect of image type (F(4)=272.73, 
P<0.001) but no significant effect of group or image type by group interaction. Post-hoc 
t-tests revealed that both healthy controls (HC) and schizophrenia patients (SCZ) rated 
the NTR images as less emotionally salient than HA- (HC: t(36)=27.28, P<0.001; SCZ: 
t(36)=18.24, P<0.001, two-tailed P), HA+ (HC: t(36)=17.35, P<0.001; SCZ: t(36)=16.69, 
P<0.001), LA- (HC: F(36)=13.45, P<0.001; SCZ: t(36)=9.01, P<0.001) and LA+ (HC: 
t(36)=10.55, P<0.001; SCZ: t(36)=9.94, P<0.001) images.  In addition, both groups 
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rated HA- images as more emotional than LA- images (HC: t(36)=15.05, P<0.001; SCZ: 
t(36)=10.31, P<0.001). This same effect was seen for the HA+ relative to the LA+ 
pictures (HC: t(36)=3.96, P<0.001; SCZ: t(36)=6.27, P<0.001) (see Fig 1). Analysis of 
the ‘person present’ task inducted to ensure that participants were paying attention to 
the emotional stimuli during encoding revealed comparable levels of attention between 
patients and healthy controls (F(1)=0.056, P>0.81).  
3.1.2. Recognition accuracy  
 
The analyses revealed a significant main effect of diagnosis (F(1)=38.62, 
P<0.001) (with better recognition accuracy in healthy controls than in schizophrenia 
patients) and a significant main effect of recognition accuracy for emotional stimuli 
(F(4)=3.76, P<0.008). A trend was revealed in the group by accuracy interaction 
(F(4)=2.39, P>0.059). Post-hoc t-tests confirmed that SCZ patients performed worse 
than HC in all experimental conditions (P<0.001, two-tailed P). Also, HC remembered 
HA+ images to a greater degree than NTR (t(36)=4.02, P<0.001) whereas no difference 
was observed between NTR and HA-, LA- and LA+ images. HC also remembered HA+ 
pictures to a greater degree than HA- pictures (t(36)=-3.97, P<0.001). SCZ patients had 
a better recognition memory of LA- images relative to NTR images (t(36)=3.43, 
P<0.001) while no significant differences was observed in recognition accuracy between 
NTR and the other emotional images. No other comparisons reached statistical 
significance (see Fig 2). 
3.2. fMRI results of individual groups  
 
3.2.1. HA negative minus neutral contrast 
 
Healthy controls activated the middle and inferior temporal cortex, middle occipital 
cortex, medial orbitofrontal cortex, superior medial frontal cortex, cerebellum, middle 
cingulated gyrus and the superior motor area. In contrast, schizophrenia patients had 
activity circumscribed to the middle temporal cortex (see Table 2 and Fig. 3).  
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 3.2.2. LA negative minus neutral contrast 
Healthy controls demonstrated activity in the middle temporal cortex, precuneus, middle 
frontal gyrus and precentral gyrus. Schizophrenia patients did not activate any 
significant voxels during retrieval of LA- relative to neutral images. 
3.2.3. HA positive minus neutral contrast  
Healthy controls activated the middle temporal cortex, inferior occipital cortex, regions 
of the prefrontal cortex, precuneus, anterior temporal pole, caudate, thalamus and 
cerebellum. Schizophrenia patients demonstrated cerebral activity in the inferior 
occipital cortex, prefrontal cortex, cerebellum, supramarginal gyrus, anterior temporal 
pole, and middle temporal gyrus (see Table 3 and Fig. 4). 
3.2.4 LA positive minus neutral contrast 
Healthy control participants activated the middle and inferior occipital cortex, calcarine 
gyrus, middle and inferior frontal cortex, superior parietal cortex, postcentral gyrus and 
superior motor area. Schizophrenia patients had brain activity restricted to the visual 
cortex. 
3.2.5. HA negative minus LA negative contrast 
 
Healthy subjects activated the fusiform and calcarine gyrus, superior frontal cortex and 
the cuneus during recognition of high relative to low arousal negative images. Regions 
activated in schizophrenia patients included fusiform and calcarine gyrus, middle and 
inferior occipital cortex, cerebellum and regions of the prefrontal cortex (see Table 4). 
3.2.6. HA positive minus LA positive contrast  
Healthy controls activated the superior parietal cortex, precuneus, and cerebellum while 
patients demonstrated brain activations in the angular gyrus, precuneus, inferior 
temporal cortex, cerebellum, anterior cingulated gyrus and regions of the prefrontal 
cortex. 
3.3. fMRI results between groups  
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3.3.1. HA negative minus neutral contrast 
Healthy participants activated the precuneus and middle frontal gyrus to a greater 
degree than patients with schizophrenia (see Table 5 and Fig. 5). 
3.3.2. LA negative minus neutral contrast 
Healthy participants had increased activations in the middle frontal gyrus, inferior 
orbitofrontal cortex and middle cingulated gyrus compared to schizophrenia patients. 
3.3.3. HA positive minus neutral contrast  
Healthy controls activated the middle frontal gyrus to a greater degree than the 
schizophrenia group while patients with schizophrenia had increased activations in the 
cerebellum, postcentral gyrus and inferior occipital cortex relative to healthy controls.  
3.3.4. LA positive minus neutral contrast 
Healthy controls activated the middle frontal gyrus and middle cingulated gyrus to a 
greater degree than schizophrenia patients. 
3.3.5. NTRS minus baseline contrast 
Patients with schizophrenia activated the precuneus, middle cingulated gyrus, anterior 
cingulated gyrus, inferior parietal gyrus, cerebellum, middle temporal and the middle 
frontal gyrus to a greater degree than the healthy comparison group during recognition 
of neutral images (Table 5).  
4. Discussion 
 
 The main goal of the present study was to investigate the neural correlates of 
emotional episodic memory in schizophrenia patients relative to healthy control 
participants. Overall, patients activated fewer regions than controls during retrieval of 
negatively valenced stimuli, but had a similar pattern of brain activations to controls 
during retrieval of positively valenced stimuli, particularly in the high arousal condition. 
Also, both groups demonstrated increased brain activations in the high relative to low 
arousing conditions. These results are intriguing considering the overall inferior 
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performance in schizophrenia patients but comparable ratings of emotional stimuli 
relative to healthy controls.  
4.1. Behavioral data 
Patients with schizophrenia rated the emotional stimuli similarly to controls. The 
finding of explicit emotional experience being similar between healthy controls and 
schizophrenia patients has been consistently reported in studies using pictures 
(Takahashi et al., 2004; Bigelow et al., 2006), films (Earnst and Kring, 1999) as well as 
words with emotional content (Koh et al., 1976; Mathews and Barch, 2004).  
In line with previous studies (Danion et al., 2003; Hall et al., 2007; Neumann et 
al., 2007), healthy controls retained more images in memory compared to patients 
regardless of emotional valence or arousal.  In discordance with our prediction, there 
were no differences in recognition accuracy between emotional and neutral images in 
patients or in control subjects (except for patient's increased memory for LA- images 
and healthy control's superior memory for HA+ images). These findings are inconsistent 
with previous reports that emotionally valenced stimuli enhance memory (Hamann, 
2001). A possible explanation for this is that emotional advantages in memory have 
been found to increase over longer time periods (LaBar and Phelps, 1998; Sharot and 
Phelps, 2004; Sharot and Yonelinas, 2008). Therefore, it is possible that the effects of 
emotionality in our paradigm would have become more evident with a longer interval 
between incidental encoding and subsequent memory. For example, a previous study 
(Dolcos et al., 2004a) investigating the neural correlates of emotional episodic memory 
in healthy individuals using similar stimuli and incidental encoding procedure as ours 
demonstrated a better memory for emotional compared to neutral stimuli after a 45-
minute delay.  
4.2. fMRI data 
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The retrieval of negative images (relative to the retrieval of neutral images) 
elicited activations in regions previously implicated in emotion processing (Phan et al., 
2002) and in episodic memory (Rugg et al., 2002).  In healthy participants the activated 
regions included the middle and inferior temporal cortex, precuneus, cerebellum, 
prefrontal cortex (medial orbitofrontal, superior and middle frontal) and middle cingulate 
gyrus, while in schizophrenia patients they were restricted only to the middle temporal 
cortex. The overall diminished activations during retrieval of negatively valenced relative 
to neutral images in schizophrenia patients are consistent with previous studies that 
have explored the processing of emotional stimuli (Schneider et al., 1998; Gur et al., 
2002; Takahashi et al., 2004) and episodic memory (Achim and Lepage, 2005b).  
Direct comparison between groups revealed that the middle frontal gyrus was 
activated to a lesser extent in schizophrenia patients compared to healthy controls 
during recognition of both negative and positive images regardless of arousal. More 
specifically, the right dorsolateral prefrontal cortex (BA 10) was activated during 
recognition memory of HA+, LA+ and LA- relative to neutral contrasts (this region was 
also activated in the HA- minus neutral contrast but did not survive the significance 
threshold) while the middle frontal gyrus at the border of the precentral gyrus (BA 6) 
was activated during the HA- and LA+ relative to neutral contrasts. In parallel with our 
finding, past episodic memory studies have documented right dorsolateral prefrontal 
cortex activation at or near Brodmann area 10 in healthy subjects (Squire et al., 1992; 
Buckner et al., 1995, 1996; Rugg et al., 1999; Achim and Lepage, 2005a). A meta-
analysis by Achim and Lepage (2005b) investigating episodic-memory related activity in 
schizophrenia, found that patients demonstrate less activity than controls in the middle 
frontal region during retrieval of episodic memories. This region has been identified as 
playing a role in post-retrieval monitoring during episodic memory retrieval with 
activations, on average, in the right middle frontal gyrus reflecting simple monitoring 
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with an additional contribution of the left middle frontal gyrus in more complex tasks 
(Achim and Lepage, 2005a). Accordingly, significant activity in the right, but not left, 
prefrontal cortex in healthy controls falls in line with our use of a simple old/new 
recognition memory task.  
Interestingly, the analysis of the neutral minus baseline contrast revealed that 
patients activated the middle frontal gyrus, precuneus and middle cingulated gyrus (as 
well as other structures), to a greater degree than healthy controls during recognition 
memory of neutral stimuli. These findings partly explain the relative underactivations in 
these regions in patients versus controls in the emotional minus neutral contrasts. 
Increased cerebral activations in response to neutral stimuli in patients with 
schizophrenia have been previously reported in the literature and fall in line with the 
idea that patients with psychosis assign emotional importance to stimuli and events that 
would normally be considered neutral (Holt et al., 2006; Surguladze et al., 2006; Hall et 
al., 2008).  
Despite atypical brain function during retrieval of negative relative to neutral 
pictures, patients did activate the middle temporal gyrus in the high arousal condition. 
This region has been implicated in a higher-order visual processing; specifically in 
perception of the social aspect of faces (Allison et al., 2000; Adolphs, 2002) including 
the processing of happy and angry faces (Critchley et al., 2000; Batty and Taylor, 
2003).  In schizophrenia the middle temporal gyrus has been activated during 
processing of negative facial expressions (Phillips et al., 1999).  Because a little over 
half of the high arousal negative images presented in our paradigm included people 
whose facial expressions were visible, we can interpret activation in this region as 
indicative of processing highly negative facial expressions by patients.   
During retrieval of highly positive images, schizophrenia patients activated 
overall similar regions as healthy controls, a finding in stark contrast to what was 
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predicted and also to what has been found in some (Schneider et al., 1998; Paradiso et 
al., 2003; Takahashi et al., 2004) but not all (Phan et al., 2002; Taylor et al., 2005; 
Reske et al., 2009; Dowd and Barch, 2010) studies that have examined the processing 
of emotional material in schizophrenia. The overlapping areas of cerebral activations 
included the middle temporal cortex, inferior occipital cortex, anterior temporal pole, 
cerebellum and regions of the prefrontal cortex (inferior and medial orbitofrontal cortex), 
most of which were also activated in healthy controls during retrieval of negative 
images.  
Activity in the orbitofrontal cortex during retrieval of positively and negatively 
valenced images is consistent with reports that this region plays a role not only in the 
processing of emotional stimuli (Bechara et al., 2000; Rolls, 2000) but in emotional 
memory as well. Specifically, significant orbitofrontal activity has been reported during 
the recollection of happy and sad life events (George et al., 1995; Heilman and Gilmore, 
1998) as well as recognition of words from negative (Lewis et al., 2005) and positive 
relative to neutral contrasts (Maratos et al., 2001).  
 In the same vein, the anterior temporal pole, a relevant component of the 
paralimbic system, has been activated during the retrieval of emotion-laden episodic 
memories (Fink et al., 1996; Dolan et al., 2000), attending to subjective emotional 
responses (Lane et al., 1997) and processing the emotional meaning of visual stimuli 
(Lane et al., 1999). Of particular importance to our findings, Beauregard and colleagues 
(Beauregard et al., 2001) reported that during the experience of sexual arousal induced 
by viewing erotic stimuli, healthy males activated paralimbic structures that 
encompassed the anterior temporal pole. We suggest that the anterior pole activations 
found in both groups during retrieval of high intensity positive images is associated with 
imparting affective tone to experience, a conclusion derived from various lines of 
evidence (Mesulam, 1985).  
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In the present study we have found both a deficit (in the high arousal negative 
condition) and preservation (in the high arousal positive condition) of activation in the 
cerebellum of schizophrenia patients during emotional memory. Our findings suggest 
that the degree of activation of the cerebellum in patients with schizophrenia is largely 
affect-dependent. There have been conflicting findings with some reporting cerebellar 
under-activations (Achim and Lepage, 2005b) and others reporting over-activations 
during episodic recognition memory (Crespo-Facorro et al., 2001) in schizophrenia. 
Additionally, research endeavours investigating schizophrenia patient’s response to 
positive and negative emotional material have either reported a lack of cerebellum 
activations or have not found differential activations of this region in response to 
pleasant relative to unpleasant stimuli (e.g. Gur et al., 2002; Paradiso et al., 2003; 
Taylor et al., 2005; Reske et al., 2009; Dowd and Barch, 2010). The fact that some 
studies have found the lateral cerebellum to be preferentially related to cognition while 
the medial cerebellum to be more associated with affect can perhaps shed some light 
on the discrepant findings (Schmahmann, 1999; 2000; 2004).  There has yet to be an 
agreement among authors concerning the role of the cerebellum in emotion in 
individuals with schizophrenia (Picard et al., 2008). In healthy subjects, activations in 
the cerebellum has been reported during the induction of feelings of sadness, anxiety 
(Reiman et al., 1997; Liotti et al., 2000), happiness (Habel et al., 2005), in evoking 
romantic love (Bartels and Zeki, 2000) and in the “feeling” experience associated with 
sexual arousal (Beauregard et al., 2001). We can posit that the erotic content in a 
sample of the high arousal positive images used in our paradigm may have contributed 
to the involvement of the cerebellum in emotional recognition memory in both the 
healthy and patient group. Future studies are awaited to explore this intriguing question.  
Previous studies exploring the processing of emotional stimuli in schizophrenia 
have documented differences in the cerebral activations associated with positive vs. 
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negative stimuli (An et al., 2003, Reske et al., 2009; Sergerie et al., 2010) or have 
reported comparable extents of cerebral activation for both positive and negative stimuli 
(Kosaka et al., 2002; Paradiso et al., 2003; Dowd and Barch, 2010). For instance, in a 
PET study of emotion recognition, Paradiso et al. (2003) reported that patients with 
schizophrenia showed little differential activation in their responding to positive versus 
negative stimuli. Reske et al. (2009) reported emotion-specific group differences in 
brain activations such that patients and healthy subjects had comparable brain 
activation patterns during the discrimination of happy faces while group differences 
surfaced in response to sad facial expressions. The discordant results in the referenced 
studies (including our own) can be attributed to differences in the experimental task 
(e.g. emotion discrimination, experience, recognition memory) and to the stimuli used 
(e.g. words, pictures, faces). Also, arousal levels were often not equated across 
emotional valence categories in the previous investigations. It is possible that when 
stimuli are appropriately matched in terms of arousal, the positive stimuli, relative to 
negative, elicit more cerebral activations, especially for highly arousing images (which is 
where our most robust finding came from). This further indicates the importance of 
considering the dimension of arousal while investigating affect.  
A surprising finding was the lack of amygdala activation during recognition of 
negative relative to neutral pictures in healthy controls. Amygdala activation during the 
retrieval of emotional memories is a consistent finding in many (e.g. LeDoux, 1993; 
Phelps and Anderson, 1997; Hamann, 2001) but not all functional neuroimaging studies 
(Taylor et al., 1998; Hamann et al., 1999). One possible explanation is the habituation 
of the amygdala to image content. Previous studies have documented that the fMRI 
BOLD signal of the amygdala attenuates with repeated presentation of negative images 
(Breiter et al., 1996; Wright et al., 2001; Fischer et al., 2003). Also, the absence of 
amygdala activation is consistent with the memory-modulation theory, which posits that 
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a central role of amygdala function is to modulate long-term memory consolidation 
(McGaugh et al., 1996; Cahill and McGaugh, 1998; Packard and Teather, 1998). 
Hence, at short delays, similar to our paradigm, little consolidation has taken place and 
so the amygdala’s role may not be detectable at this point.  
Together, the present findings suggest a neurofunctional anomaly in the use of 
negative affect, but intact functional circuitry of positive affect during episodic memory 
retrieval in schizophrenia patients. This was observed despite comparable recognition 
memory for negative and positive stimuli in the patient group. Interestingly, it seems that 
an interaction between valance and arousal is also at play because the effect was only 
seen for the high arousal positive contrast. Particularly, activations in regions that have 
previously been reported to be functionally impaired during the processing of emotional 
material and episodic memory in schizophrenia (e.g. anterior temporal pole, 
orbitofrontal cortex, cerebellum) were intact during the high arousal positive condition 
suggesting that their role in emotional episodic memory is affect dependent rather than 
being dysfunctional altogether.  
With regards to arousal, both healthy controls and patients with schizophrenia 
showed an increase in cerebral activations in the high relative to low arousal contrasts 
for both positive and negative stimuli. It is worth noting that analysis of the main effect of 
arousal (i.e. brain activations in the high compared to low arousal conditions with 
positive and negative images combined) yielded a similar pattern of results. Our 
findings parallel neuroimaging studies of emotion processing in healthy individuals.  For 
example, Lane and colleagues (Lane et al., 1999) examined the impact of valence and 
arousal during visual processing of pictures and found increased activations during 
processing of high intensity relative to low intensity emotion in extrastriate visual cortex 
and anterior temporal areas. Similarly, Bradley and colleagues (2003) reported more 
widespread occipital cortex activity when healthy participants viewed stimuli associated 
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with primary motive states (e.g., victims of violent death, erotica) compared to less 
arousing and neutral stimuli. It was suggested that this increase in activity reflected 
“motivated attention” in which appetitive or defensive motivational engagement guided 
attention and facilitated perceptual processing of survival-relevant stimuli.  
Investigating the impact of arousal on memory and emotion in schizophrenia is 
limited. In one previous study (Hooker and Park, 2002) patients with schizophrenia were 
able to identify vocal affect of high emotional intensity better than that of low emotional 
intensity.  The observation of a comparable subjective emotional experience between 
schizophrenia patients and healthy controls has been documented in numerous studies 
(Berenbaum and Oltmanns, 1992; Kring et al., 1993; Kring and Neale, 1996; Iwase et 
al., 1999; Aghevli et al., 2003; Kring and Moran, 2008). The results of our study are no 
different and, in fact, we have found that this comparable individual experience of 
emotion was demonstrated at the level of arousal where patients with schizophrenia, 
similarly to controls, rated high arousing stimuli as more emotionally salient than low 
arousing stimuli. Taken together, these behavioral and neuroimaging data suggest that 
schizophrenia patients show less of an emotional deficit relative to what has previously 
been reported in studies exploring the cerebral activations associated with the 
recognition and experience of emotional stimuli in individuals with schizophrenia 
(Schneider et al., 1998; Gur et al., 2002; Takahashi et al., 2004). 
The interpretation of this study is limited by the fact that we did not include a 
means to assess the subjects' potential encoding strategies during scanning. Even 
though the participants were not instructed to try and remember the pictures presented 
during encoding, they were still aware that they were going to undergo a subsequent 
memory task. Thus, it is possible that both groups differed in their tendency to 
instinctively use encoding strategies as well as in their ability to effectively use such 
strategies. This supposition is strengthened in light of evidence that faulty mnemonic 
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processes during encoding underlie memory impairments in schizophrenia (Koh and 
Peterson, 1978; Brebion et al., 1997; Iddon et al., 1998).  
We would also like to acknowledge that because old and new images were 
randomly intermixed within each block, cerebral activations associated with only correct 
retrieval of stimuli into memory could not be ascertained. Because of this it is possible 
that other processes, rather than simply recognition, could have affected the pattern of 
cerebral activations observed which is indicative that our data more likely reflected an 
attempted retrieval process. For instance, potential attention lapses during the block 
could have caused the decreased performance and brain function in patients 
particularly during memory of negatively valenced stimuli. Nonetheless, the overall main 
goal of this study was to assess the performance and brain function associated with 
recognition of emotional stimuli regardless of whether the stimuli were old or new. Also, 
despite the fact that brain activity in response to new stimuli and old stimuli were not 
differentiated, both healthy controls and patients with schizophrenia (though to a lesser 
extent) demonstrated accuracy significantly above chance indicating that an accurate 
recognition process was taking place.  
To conclude, our data suggest that the failure to activate brain regions during 
retrieval of emotional stimuli from memory in patients with schizophrenia is dependent 
on whether these stimuli carry a positive or negative valence. Moreover, the effects of 
arousal demonstrate that the experience of emotion is relatively intact in schizophrenia 
patients relative to what has previously been reported in functional neuroimaging 
studies. 
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Figure Legend: 
 
Figure 1:  
Subjective ratings scores in healthy controls and schizophrenia patients for all 
experimental conditions. 
Bars represent standard error of the mean 
HA- = high arousal negative, HA+= high arousal positive, LA-=low arousal negative, 
LA+= low arousal positive, NTR=neutral 
 
Mean(SE) : HA- : Healthy controls(HC)= 6.92(0.17), Schizophrenia (SCZ)= 6.67(0.22); 
HA+: HC= 5.34(0.22), SCZ= 5.79(0.20); LA-: HC= 3.87(0.18), SCZ= 3.97(0.25); LA+: 
HC= 4.15(0.22), SCZ=4.17(0.25); NTR: HC=1.10(0.18), SCZ= 1.74(0.23) 
 
Figure 2: 
Recognition accuracies in healthy controls and schizophrenia patients for all 
experimental conditions. 
Bars represent standard error of the mean 
HA- = high arousal negative, HA+= high arousal positive, LA-=low arousal negative, 
LA+= low arousal positive, NTR=neutral 
 
Mean(SE) : HA- : Healthy controls(HC)= 0.79(0.023), Schizophrenia (SCZ)= 
0.57(0.045); HA+: HC= 0.89(0.023), SCZ= 0.55(0.049); LA-: HC= 0.82(0.038), SCZ= 
0.60(0.044); LA+: HC= 0.84(0.023), SCZ= 0.57(0.053); NTR: HC= 0.79(0.022), SCZ= 
0.49(0.038) 
 
Figure 3:  
Cerebral activations associated with the retrieval of high arousal negative images (top) 
and low arousal negative images (bottom) in schizophrenia patients and healthy 
controls.  
HC=healthy controls, SCZ=schizophrenia patients 
HA-=high arousal negative, LA-=low arousal negative 
The colored bar represents the range of z-scores of the cerebral activations with 
significance increasing from 3 (pink color) to 7 (red color). 
 
Figure 4: 
Cerebral activations associated with the retrieval of high arousal positive images (top) 
and low arousal positive images (bottom) in schizophrenia patients and healthy 
controls.  
HC=healthy controls, SCZ=schizophrenia patients 
HA+=high arousal positive, LA+=low arousal positive 
The colored bar represents the range of z-scores of the cerebral activations with 
significance increasing from 3 (pink color) to 7 (red color). 
 
Figure 5: 
Cerebral activations associated with group differences during the retrieval of negative 
relative to neutral images (top) and positive relative to neutral images (bottom) in 
schizophrenia patients and healthy controls.  
HC=healthy controls, SCZ=schizophrenia patients 
HA+=high arousal positive, LA+=low arousal positive, HA-=high arousal negative, LA-
=low arousal negative 
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The colored bar represents the range of z-scores of the cerebral activations with 
significance increasing from 0 (pink color) to 3 (red color). 
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Figure 1. Subjective ratings of emotional stimuli in healthy controls and 
schizophrenia patients 
 
 
Figure 2. Recognition accuracy of emotional stimuli in healthy controls and 
schizophrenia patients 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Table 1. Demographic and clinical data of participants 
 Schizophrenia patients Healthy controls  
 Mean SD Mean SD P (Independent 
sample, two-tailed) 
Age 32.46 7.66  31.81 6.91 0.70 
Parental SES 2.36 1.09 2.68 0.88 0.18 
Sex (% male) 51 - 51 - - 
Handedness (% right) 89 - 91 - - 
Medication (chlorpromazine 
equivalence) 
613.92 361.02 - - - 
PANSS Positive 18.84 6.93 - - - 
PANSS Negative 12.59 10.95 - - - 
PANSS General 24.05 22.59 - - - 
PANSS=Positive and Negative Syndrome Scale, SES= Socioeconomic status; 
SD=standard deviation 
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Table 2. fMRI BOLD activations during retrieval of negatively charged images 
relative to neutral images 
 
L/R=Left/Right, BA=Brodmann areas, HC=Healthy controls, SCZ=Schizophrenia 
patients, *=Brain region is part of the same cluster as above 
 
 
 
 
 
 
 
 
 
 
 
 
  
L/R 
 
Brain region 
 
BA 
MNI coordinates  
Z-score 
 
voxels 
 
P value x y Z 
HA negative 
minus neutral 
         
HC R Middle temporal cortex 19 46 -70 0 6.77 339 0.001 
L Middle occipital cortex 19 -46 -74 7 6.70 * 0.001 
R Inferior temporal cortex 20 46 -49 -18 6.17 * 0.001 
R Precuneus 7 7 -52 52 5.27 * 0.001 
L Medial orbitofrontal cortex 11 0 52 -18 4.23 40 0.001 
L Superior medial frontal 
cortex pole 
10 -7 63 21 3.83 46 0.003 
L Middle cingulate cortex 24 0 7 32 3.81 64 0.005 
R Superior motor area 6 4 21 63 3.28 14 0.012 
 L Cerebellum - -10 -74 -42 3.95 63 0.004 
 R Cerebellum - 14 -74 -46 3.88 * 0.004 
SCZ R Middle temporal cortex 19 52 -74 0 3.96 40 0.002 
LA negative 
minus neutral 
         
HC R Middle temporal cortex 37 52 -63 7 4.42 217 0.001 
L Middle temporal cortex 37 -52 -63 14 4.24 166 0.001 
L Middle frontal cortex 8 -32 32 46 3.7 40 0.005 
L Precuneus 7 -4 -56 52 3.88 85 0.003 
 L Precentral gyrus 6 -46 4 49 3.29 18 0.011 
SCZ No significant voxels activated  
Inferior occipital cortex 
18 
-39 
-84 
-11 
6.27 
5251 
0.001 
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Table 3. fMRI BOLD activations during retrieval of positively charged images 
relative to neutral images 
 
L/R=Left/Right, BA=Brodmann areas, HC=Healthy controls, SCZ=Schizophrenia 
patients, *=Brain region is part of the same cluster as above 
 
 
 
Group 
 
L/R 
 
Brain region 
 
BA 
MNI coordinates  
Z-score 
 
voxel
s 
 
P value x y z 
HA positive minus 
neutral 
         
HC R Middle temporal cortex 19 49 -70 0 5.79 263 0.001 
L Middle temporal cortex 19 -49 -70 7 5.49 293 0.001 
L Inferior occipital cortex 18 -46 -80 -10 4.93 * 0.001 
L Calcarine gyrus 18 -4 -88 0 4.2 253 0.001 
L Rectus gyrus 11 0 52 -18 4.85 98 0.001 
R Medial orbitofrontal cortex 11 4 38 -14 3.79 * 0.001 
R Middle frontal cortex 6 46 0 60 3.60 17 0.009 
R Inferior frontal cortex 45 56 35 0 4.09 67 0.002 
R Anterior temporal pole 38 32 14 -28 3.88 47 0.003 
L  Precuneus 7 0 -60 56 3.50 85 0.004 
R Caudate - 4 4 -4 3.41 12 0.016 
R Thalamus - 10 -28 -4 3.25 17 0.012 
 L Cerebellum - -14 -74 -38 3.21 5 0.01 
SCZ L Inferior occipital cortex 19 -46 -74 -4 5.47 236 0.001 
 R Inferior occipital cortex 19 46 -77 -4 5.19 * 0.001 
 R Calcarine 17 10 -88 4 5.14 * 0.001 
 L Rectus gyrus 47 -14 21 -10 4.07 69 0.002 
 R Medial orbitofrontal  cortex 32 4 32 -10 3.80 * 0.001 
 L Inferior orbitofrontal  cortex 47 -24 32 -10 3.64 * 0.004 
 L Superior frontal cortex 8 -21 32 49 3.70 82 0.003 
 R Anterior temporal pole 38 42 10 -24 3.36 38 0.006 
 R Middle temporal cortex 21 60 -4 -21 3.26 14 0.008 
 L Supramarginal gyrus 40 -63 -38 32 3.57 34 0.005 
 R Cerebellum - 24 -24 -28 3.59 27 0.006 
LA positive minus 
neutral 
         
HC R Middle occipital cortex 19 46 -74 0 6.23 237 0.001 
 
 
L Inferior occipital cortex 19 -42 -77 -7 5.57 * 0.001 
L Calcarine gyrus 17 -10 -84 4 4.52 * 0.001 
R Middle frontal cortex 6 42 -7 52 3.59 48 0.007 
R Inferior frontal cortex 46 56 32 7 3.48 12 0.017 
R Superior parietal cortex 7 28 -56 56 3.52 21 0.016 
 L Postcentral gyrus 2 -42 -28 52 3.37 8 0.018 
 L Superior motor area 6 -7 10 66 3.33 28 0.007 
SCZ R Inferior occipital cortex 19 42 -74 -4 4.90 191 0.001 
 R Calcarine gyrus 17 14 -88 4 4,34 * 0.001 
 L Cacarine gyrus  17 -10 -84 4 4.24 * 0.001 
 L Inferior occipital cortex 19 -38 -74 -10 3.49 26 0.011 
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Table 4. fMRI BOLD activations during retrieval of high arousal relative to low 
arousal images 
 
Group 
 
L/R 
 
Brain region 
 
BA 
MNI coordinates  
Z-
score 
 
voxels 
 
P value x y z 
HA negative minus 
LA negative 
         
HC R Fusiform gyrus 37 38 -66 -14 4.80 320 0.001 
L Fusiform gyrus 37 -35 -66 -14 4.23 * 0.001 
R Calcarine gyrus 17 10 -91 4 4.40 * 0.001 
R Middle occipital cortex 19 35 -80 18 3.85 73 0.001 
 R Cuneus 19 7 -88 42 3.17 57 0.032 
 R Superior frontal cortex 6 38 -7 63 3.37 35 0.042 
SCZ L Calcarine gyrus 17 -10 -94 -7 4.47 114 0.001 
 R Fusiform gyrus 37 42 -49 -21 4.05 * 0.001 
 L Inferior occipital cortex 19 -49 -77 -10 3.53 43 0.004 
 R Middle occipital cortex 19 38 -77 10 3.49 13 0.013 
 L Inferior orbitofrontal coretx 47 -28 28 -14 3.27 8 0.014 
 L Superior orbitofrontal cortex 47 -21 21 -14 3.27 * 0.014 
 R Cerebellum - 14 -66 -56 3.71 9 0.012 
HA positive minus 
LA positive 
         
HC R Superior parietal cortex 7 14 -77 52 3.72 91 0.007 
 
 
R Precuneus 7 7 -74 60 3.48 * 0.007 
L Precuneus 4 0 -63 66 3.05 * 0.016 
SCZ R Angular gyrus 39 38 -63 35 4.42 105 0.001 
 R Precuneus 7 4 -63 32 4.23 * 0.001 
 L Angular gyrus 39 -42 -60 38 3.86 71 0.002 
 R Inferior temporal cortex 37 60 -49 -10 3.78 13 0.009 
 R Anterior cingulated cortex 32 18 42 4 3.37 18 0.01 
 R Medial frontal cortex 32 10 46 0 3.26 * 0.01 
 L Superior frontal cortex 9 -18 42 35 3.48 34 0.01 
 R Middle frontal cortex 9 35 21 38 3.38 47 0.006 
 R Inferior frontal cortex 9 42 14 35 3.29 * 0.006 
 L Cerebellum - -35 -56 -49 3.42 16 0.012 
L/R=Left/Right, BA=Brodmann areas, HC=Healthy controls, SCZ=Schizophrenia 
patients, *=Brain region is part of the same cluster as above 
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Table 5. fMRI BOLD activations of group differences during retrieval of emotional 
images relative to neutral and neutral images relative to baseline.  
 
Group 
 
L/R 
 
Brain region 
 
BA 
MNI 
coordinates 
 
Z-
score 
 
voxels 
 
P value x y Z 
HA negative minus 
neutral 
         
HC > SCZ R Precuneus 7 4 -46 56 2.63 74 0.004 
R Middle frontal cortex 6 38 0 56 2.58 21 0.005 
LA negative minus neutral          
HC > SCZ R Middle frontal cortex 10 38 49 24 2.87 44 0.002 
L Inferior orbitofrontal 
cortex 
47 -24 32 -
10 
2.72 10 0.003 
R Middle cingulate cortex 7 1 -38 46 2.57 34 0.005 
HA positive minus neutral  
HC > SCZ R Middle frontal cortex 10 42 46 24 2.82 78 0.002 
SCZ > HC R Cerebellum - 21 -28 38 2.56 118 0.005 
 L Postcentral gyrus 6 -63 -4 32 2.63 72 0.004 
 R Inferior occipital cortex 18 38 -84 -4 3.03 235 0.001 
LA positive minus neutral  
HC > SCZ R Middle frontal cortex 10 38 49 21 3.67 37 0.001 
 R Middle frontal cortex 6 38 -4 56 3.64 * 0.001 
 R Middle cingulate cortex 31 7 -21 46 3.50 28 0.001 
NTR minus baseline  
SCZ > HC R Precuneus 5 4 -42 56 3.34 291 0.001 
 R Middle cingulate cortex 31 7 -21 42 3.30 * 0.001 
 R Middle frontal cortex 9 46 28 35 3.02 26 0.002 
 R Middle frontal cortex 6 42 0 52 3.02 41 0.001 
 L Inferior parietal cortex 40 -42 -42 46 3.16 49 0.001 
 L Anterior cingulate cortex 32 -10 32 -10 3.23 23 0.001 
 L Cerebellum - -24 -88 -24 3.05 16 0.001 
 L Middle temporal cortex 39 -56 -63 21 2.90 5 0.002 
L/R=Left/Right, BA=Brodmann areas, HC=Healthy controls, SCZ=Schizophrenia 
patients, *=Brain region is part of the same cluster as above 
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Abstract  
 
Background: Individuals with schizophrenia show prominent deficits in emotional 
episodic memory. Examining sex-specific differences in the neural correlates of 
emotional memory in schizophrenia patients is non-existent, despite reports of sex 
differences in healthy individuals. The present study aimed to compare cerebral 
activations in schizophrenia and healthy men and women during the recognition 
memory of emotional images.  
Methods: Using fMRI, 41 schizophrenia patients (20 women) were compared to 41 
healthy participants (19 women) while performing a yes/no recognition paradigm with 
positive, negative and neutral images. 
Results: There were no sex differences in performance. Compared to healthy women, 
schizophrenia women showed a decrease in brain activations in cortical (e.g. middle 
cingulate) and subcortical limbic structures (e.g. amygdala) during recognition of 
negative images and decreased activations during the positive condition in the 
cerebellar vermis, middle and inferior frontal gyrus. Schizophrenia men had increased 
activations compared to healthy men in the medial prefrontal gyrus during recognition of 
negative stimuli and a substantial increase in brain activity during the recognition of 
positive pictures in parietal, temporal and limbic structures. Correlation analysis 
revealed significant relationships between brain function and symptoms during positive 
emotional memory in women and during negative emotional memory primarily in men.  
Conclusion: We uncovered sex-specific differences in the cerebral activations 
associated with emotional memory in healthy and schizophrenia individuals. The extent 
of these sex differences depended on the valence of the images. These findings 
demonstrate the importance of investigating men and women with schizophrenia 
separately in the context of emotional and cognitive tasks.  
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Introduction  
 
The brains of men and women diverge in several ways and a plethora of sex 
differences in cognitive functions (Halpern, 1997; Herlitz & Rehnman, 2008; Kimura, 
2004; Levy & Heller, 1992) and emotional processing (Bradley et al., 2001; Derntl et al., 
2010; Hamann & Canli, 2004; Kring & Gordon, 1998; McLean & Anderson, 2009; 
Wager et al., 2003) have been documented, including memory for emotionally laden 
events. Studies have found that women possess a superior memory for emotional 
events compared to men (Andreano & Cahill, 2009; Cahill, Gorski, et al., 2004; Canli et 
al., 2002; Fujita et al., 1991; Seidlitz & Diener, 1998) and these differences have been 
attributed to underlying disparities between the sexes in the strategies used to process 
information (Fujita, et al., 1991; McGivern et al., 1997; Meyers-Levy & Tybout, 1989; 
Seidlitz & Diener, 1998). Complementing the behavioral studies, functional 
neuroimaging reports have pointed to distinct patterns of neural activity in men and 
women during both encoding and recognition of emotional stimuli (Bremner et al., 2001; 
Cahill, Uncapher, et al., 2004; Canli, et al., 2002; Ino et al., 2010; Mackiewicz et al., 
2006; Piefke et al., 2005) 
Schizophrenia, a heterogeneous and complex psychiatric disorder, is 
characterized by prominent disturbances in cognitive and emotional functioning 
(Heinrichs & Zakzanis, 1998; Kohler et al., 2000; Kohler & Martin, 2006; Rund & Borg, 
1999) including the processing of emotional memories (for a Review see Herbener, 
2008). Similarly to the general population, differences between men and women in 
cognitive and emotional functioning have been documented. Male patients tend to 
exhibit more poverty of speech and blunted affect, whereas female patients display 
more inappropriate affect and certain delusions and hallucinations (Andia et al., 1995; 
Goldstein & Link, 1988; Leung & Chue, 2000; Rector & Seeman, 1992; Tien, 1991). In a 
study of facial emotion processing, Scholten and colleagues (2005) observed a clear 
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sex difference in the ability to recognize facial emotions, especially negative ones, with 
women outperforming men. With regards to cognition the results have been more 
inconsistent. Some reports have documented greater impairment in schizophrenia men 
compared to women on tasks of attention, language, memory and executive functioning 
(Goldstein et al., 1998; Lewine et al., 2006; Longenecker et al., 2010; Seidman et al., 
1997; Torniainen et al., 2011; Vaskinn et al., 2011; Walder et al., 2006), while others 
have reported the opposite effect (Hoff et al., 1998; Lewine et al., 1996; Torniainen, et 
al., 2011) or have not uncovered any significant sex-specific differences in cognitive 
performance (Andia, et al., 1995; Guillem et al., 2009; Lewine, et al., 2006; Shipman et 
al., 2009). The small number of studies that have examined sex differences in cerebral 
activations associated with cognition (e.g. mental rotation, episodic memory) (Guillem, 
et al., 2009; Jiménez et al., 2010) and emotional processing (e.g. experience of 
emotion) (Mendrek et al., 2007; Mendrek, 2009) in schizophrenia have provided 
evidence of distinct patterns of activations between men and women. The overall 
findings pointed towards an alteration of the normal sexual dimorphism in cerebral 
activations in individuals with schizophrenia.  
To our knowledge there are no published reports of sex differences in the neural 
circuitry associated with emotional episodic memory in patients with schizophrenia, 
although a few functional neuroimaging studies have examined the overall differences 
between schizophrenia patients and healthy controls. For instance, using functional 
magnetic resonance imaging (fMRI) Whalley et al. (2009) reported robust medial 
temporal lobe activations in patients with bipolar disorder, patients with schizophrenia 
and healthy controls during memory encoding that correlated significantly with 
subsequent recognition memory performance. Another fMRI study implemented an 
emotional memory paradigm with faces and reported emotion-specific differences in 
cerebral activations (e.g. hippocampus, parahippocampal and superior frontal gyrus) 
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associated with memory response bias in patients with schizophrenia and healthy 
subjects (Sergerie et al., 2010). More recently, we observed an atypical pattern of brain 
function during retrieval of negative pictures, but intact functional circuitry during 
memory for positive pictures (particularly highly arousing pictures) in schizophrenia 
patients (Lakis et al., 2011). Although individuals with schizophrenia appear to be 
impaired in memory for emotional experiences, the evidence of neurofunctional 
correlates of episodic memory deficits in this psychiatric population is still limited and 
investigation of sex differences is non-existent.  
The primary aim of the present study was to explore brain activations in men 
and women with schizophrenia, during recognition of positively and negatively valenced 
pictures, relative to same-sex healthy comparison groups. Our hypotheses were based 
on existing literature (Canli, et al., 2002; Piefke, et al., 2005; Seidlitz & Diener, 1998) as 
well as previous results obtained by our group (Mendrek et al., 2010 ; Mendrek, et al., 
2007; Mendrek, 2009). Behaviorally, the cognitive-style hypothesis posits that men and 
women may differ in the way they encode, rehearse and think about emotional 
experiences that will ultimately lead to differences in performance (with women 
outperforming men; Seidlitz & Diener, 1998) and to qualitative differences in the pattern 
of cerebral activations during processing of emotional memories (Bremner, et al., 2001; 
Canli, et al., 2002; Piefke, et al., 2005). Accordingly, we predicted that schizophrenia 
patients would be characterized by a decreased recognition accuracy compared to 
healthy subjects, but that women in both groups would have a superior recognition 
memory for emotional stimuli relative to men. With regards to cerebral functioning, we 
postulated that men and women in both groups would activate qualitatively distinct 
pattern of cerebral activations in regions previously implicated in emotion and episodic 
memory processes (e.g. regions of limbic and paralimbic cortex, parietal and prefrontal 
cortex) (Dolcos et al., 2004a, 2004b; Hamann, 2001; LaBar & Cabeza, 2006; Phan et 
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al., 2002). In addition, based on existing findings (Mendrek, et al., 2010 ; Phillips et al., 
2003; Phillips et al., 1999; Stip et al., 2005), we predicted significant correlations 
between negative symptoms and activations in cortical structures (e.g. prefrontal, 
cingulate cortex), and between positive symptoms and activations in subcortical limbic 
structures (e.g. amygdala, hippocampus). Moreover, because it has been documented 
that schizophrenia men are typically more affected by negative symptoms and women 
by positive symptoms (Leung & Chue, 2000), we hypothesized that deficient brain 
activations during emotional memory in men would be mediated primarily by negative 
symptomatology, while positive symptoms would play a greater role in a distorted 
cerebral function in women.  
Methods and Materials 
Subjects 
Forty-one patients with schizophrenia (21 men, 20 women) meeting the DSM-IV 
criteria for schizophrenia (APA, 1994), in a stable phase of their illness (defined as no 
relapse within the last two months and no change in their antipsychotic treatment within 
the last month) and 41 healthy controls (22 men, 19 women) participated in the study.  
The groups were matched for age, handedness (Edinburgh Inventory) (Oldfield, 1971) 
and parental socio-economic status (National Occupational Classification; NOC) 
(Census, 2001) (Table 1).  
All patients were re-evaluated by experienced psychiatrists before being 
assigned to the research group (DSM-IV, criteria A-E); affective, schizoaffective and 
schizophreniform psychoses were excluded. Control participants were screened with 
the non-patients edition of the Clinical Interview for DSM-IV (SCID) (Spitzer et al., 
1992). Symptom severity was rated according to the positive and negative syndrome 
scale (PANSS) (Kay et al., 1987).  Illness onset was defined as the date of the first 
psychiatric consultation. All the patients received at least one atypical antipsychotic (26 
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patients received one, 15 received two. In chlorpromazine equivalence: Clozapine: 
n=20, mean dosage= 835 mgs ± 215.27 mgs; olanzapine: n= 11, mean dosage= 280 
mgs ± 113.53 mgs; risperidone: n=15, mean dosage= 111.11 ± 58.65 mgs; quetiapine: 
n=9, mean dosage= 324.07 mgs ± 183.17 mgs; ziprasidone: n=2 mean dosage= 166.67 
mgs ± 47.14).  
General exclusion criteria included age below 18 or above 45 years, past or 
present neurological or Axis-I psychiatric disorder, alcoholism or drug abuse, non 
compliance with testing procedures, or any contra-indication for MRI (e.g., cardiac 
pacemaker, aneurysm clip, etc.) 
In agreement with the Declaration of Helsinki, written informed consent was 
obtained prior to participation in the experiment. The ability of schizophrenia patients to 
give informed consent was established using the guidelines of the Canadian Psychiatric 
Association. The study was approved by the ethics committees of the Fernand-Seguin 
Research Center of the Louis-H Lafontaine Hospital and the Regroupement 
Neuroimagerie Québec. 
Procedure 
Prior to the memory task, participants passively viewed blocks of emotionally 
positive, negative, and neutral pictures while in the fMRI scanner (i.e. incidental 
encoding task). The stimuli were selected from the International Affective Picture 
System (IAPS) (Lang et al., 1988) to fit three experimental conditions: positive, negative 
and neutral content. Each image category was presented in separate blocks. Images 
with positive and negative valence were matched based on normative arousal ratings 
and all images were matched for content (e.g. number of people, animals, landscapes). 
This emotion processing task was followed by an unrelated cognitive task with a 
duration of 15 minutes as a means of separating both incidental encoding and 
subsequent emotional recognition memory.  
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The subsequent emotional memory task consisted of viewing 48.5-second 
blocks of emotionally positive, negative, and neutral pictures where 50% of the stimuli in 
each block originated from the incidental encoding task, while the other 50% were new. 
There were 16-second periods of rest separating the blocks from one another.  Each 
block contained 10 images and was repeated 4 times. Each picture appeared for 3000 
ms followed by a blank screen with a fixation point for an average of 1.75 s (ranging 
from 1 to 2.5 s and giving an average inter-stimulus interval (ISI) of 4.75 s). During this 
memory task, participants’ were to determine, by pressing the correct button, which of 
the stimuli were old and which were new. To assess the participants subjective 
emotional responses to the presented images, immediately at the end of the fMRI 
session, participants were re-presented with the images of each block and were asked 
to rate on a scale ranging from 0 (absence of any emotional reaction) to 8 (strongest 
emotion ever felt in one's lifetime) the intensity of experienced emotion for each block of 
stimuli. 
fMRI data acquisition and analyses 
Blood oxygenated dependent level (BOLD) signals were recorded using a 
single-shot, gradient-recalled echo-planar imaging sequence [repetition time (TR) = 
3000 ms, echo time (TE) = 30 ms, flip angle = 90 degrees, matrix 64 x 64 voxels] on a 
MRI Siemens TRIO system at 3.0 Tesla, which is operational at the Functional 
Neuroimaging Unit at the University of Montreal Geriatric Institute.  The functional 
volumes were then registered to individual high-resolution co-planar anatomical images 
taken during the same scanning session (three-dimensional, spoiled gradient echo 
sequence; 176 slices, slice thickness = 1 mm, TR = 19 ms, TE = 4.92 ms, flip angle = 
25"; matrix 256 x 256 voxels) to better identify activated structures.  
The fMRI data were analyzed using statistical parametric mapping software 
(SPM5; Wellcome Department of Cognitive Neurology, London, UK) according to 
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methods outlined by Friston and colleagues (Friston, 1995).  Functional images were 
realigned to the mean volume of each session to correct for artifacts due to subject 
motion, were spatially normalized into the standardized brain template (voxel size: 
3.5mm x 3.5mm x 3.5mm) and were spatially smoothed with a three-dimensional 
isotropic Gaussian kernel (12 mm FWHM) to improve the signal-to-noise ratio.   
Statistical analyses were carried out using a standard peak-detection approach 
and the general linear model implemented in SPM5 to identify the dynamic cerebral 
changes associated with emotional episodic memory.  First, fMRI data of each 
participant were analyzed using a fixed-effects model to investigate individual brain 
activation maps and to contrast the brain activity associated with different conditions. 
The fixed-effects analysis produced individual contrast images that were then used as 
raw data for the implementation of a random-effects model to investigate the pattern of 
activations during the different emotional contrasts (positive minus neutral and negative 
minus neutral) in each group (i.e. healthy men, healthy women, schizophrenia men and 
schizophrenia women). The literature exploring sex differences in the neural correlates 
of emotional episodic memory in patients with schizophrenia is scarce and so an 
exploratory whole brain analysis was performed. One-sample t-tests were conducted for 
each group to subtract brain activations associated with neutral from that associated 
with emotional stimuli (emotional minus neutral). These activations maps were 
thresholded at the level of p=0.01 with the FDR correction at the whole brain level and 
regions were considered significant at a p < 0.001. We also examined any potential 
differences between groups within the same sex (e.g. activations in healthy women 
minus activations in schizophrenia women) using a two-sample t-test. Due to the strict 
character of the second-level analysis based on a random-effects model the statistical 
maps were thresholded at the level of p=0.005 uncorrected for multiple comparisons 
and regions were considered to be significant at a p < 0.005. Similar and more liberal 
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thresholds were used in recent fMRI studies because the analyses were based on a 
random effect model (Aleman & Swart, 2008; Jiménez, et al., 2010; Lakis, et al., 2011). 
However, the majority of the activation was also significant when corrected for multiple 
comparisons, suggesting that it is unlikely that they were type I errors. In addition to the 
whole brain analysis, the hippocampus, amygdala and medial prefrontal cortex 
bilaterally were selected as a priori regions of interests (ROI) based on previous 
functional neuroimaging studies of emotional memory (Dolcos, et al., 2004a, 2004b; 
Hamann, 2001; Kensinger & Corkin, 2004; LaBar & Cabeza, 2006). The centers for 
each of our a priori ROIs were produced using the Mask for ROI Analyses software 
(MARINA) (Walter et al., 2003). This software provides 3D masks based on the 
Automated Anatomical Labelling (AAL) (Tzourio-Mazoyer et al., 2002). AAL uses the 
anatomical boundaries of each region using the MNI template as a reference. A search 
sphere (radius=16 mm) was applied to the centre of each ROI using the small volume 
correction function in SPM5 except for the amygdala in which a sphere of 8 mm was 
implemented. The AAL tool in SPM provided the anatomic labeling of each activation 
peak within the ROI. For the a priori search, a probability threshold for multiple 
comparison of a corrected p < 0.05 and a z-score 1.67 was used (Poline et al., 1997). 
Effects at each voxel of the brain was estimated using the general linear model and 
voxel values for the contrasts of interest generated statistical parametric maps of the t 
statistic (SPM t) that were subsequently transformed to the unit normal distribution 
(SPM Z).  
 To assess correlations between clinical symptoms and brain function, second-
level regression analyses were performed in SPM5. Positive and negative symptoms 
were entered as covariates of interest that were correlated first with brain function 
during recognition memory of positively valenced images and then with the cerebral 
activations associated with memory of negative stimuli. Statistical maps were 
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thresholded at a level of p=0.001 uncorrected (Whalley, et al., 2009), and regions were 
considered significant at a p<0.001. These correlation analyses were done for 
schizophrenia men and women separately at the whole-brain level. For the first and 
second-level statistical analyses only contiguous voxels greater than or equal to 5 were 
considered as significant.  
Behavioral data analyses: 
Recognition accuracy was measured by taking into account both the hit and 
false alarm rate. The hit rate is defined as the number of old slides correctly identified 
as having been seen before divided by the total number of old slides and false alarm 
rate is characterized by the number of distractor slides incorrectly identified as seen 
before divided by the total number of distractor slides (Hall et al., 2007). The recognition 
accuracy was calculated as the difference between the hit and false alarm rate with a 
maximum value of +1 (perfect recognition of stimuli presented during incidental 
encoding) and a minimum value of -1 (falsely reporting that they had previously seen 
every new picture).  
To examine ratings of emotional stimuli and recognition accuracy we conducted 
a repeated measures ANOVA with image type (i.e. positive, negative and neutral) as a 
within subject factor and group and sex as between subject factors. The source of 
significant group or stimulus effects was further investigated using post hoc t-tests. 
 Recognition accuracy data from 4 subjects (one in each group) were missing 
due to recording errors while the participants were being scanned and the subjective 
rating data from 4 subjects were missing (2 healthy women, 1 healthy man and 1 
schizophrenia man). The demographic, clinical and behavioral data was analyzed using 
the IBM Statistical Package for the Social Sciences (SPSS), version 19.0. 
Results 
Behavioral results 
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For the subjective emotional responses to the images (Figure 1), we found a 
significant main effect of condition (F(2)=511.55, p<0.001) as well as a significant 
interaction between group and condition (F(2)=8.26, p<0.001). There were no 
significant group (F(1)=2.11, p>0.05) or sex differences (F(1)=0.081, p>0.05). Post-hoc 
t-tests revealed that healthy controls rated both the positive and negative images as 
being more emotionally salient than the neutral images (Positive vs. Neutral: 
t(37)=16.69, p<0.001; Negative vs. Neutral: t(37)=22.97, p<0.001). The same pattern 
was seen in the patient group (Positive vs. Neutral: t(39)=14.84, p<0.001; Negative vs. 
Neutral: t(39)=15.78, p<0.001). Further investigation revealed that despite a lack of 
group differences in the experience of emotional stimuli, individuals with schizophrenia 
rated the neutral images as being more emotional than did healthy subjects (t(77)=-
3.24, p<0.002). 
The analysis of recognition accuracy (Figure 2) revealed a significant main effect 
of group (F(1)=39.184, p<0.001), a significant main effect of condition type (F(2)=13.69, 
p<0.001) and an interaction between condition type and group (F(2)=6.73, p<0.002). No 
significant effect of sex was observed (F(1)=0.045, p>0.05). Post-hoc t-tests confirmed 
that patients with schizophrenia had a worse recognition memory performance relative 
to the healthy controls for the positive (t(77)=6.63, p<0.001), negative (t(77)=3.51, 
p<0.001) and neutral pictures (t(77)=6.33, p<0.001). In addition, the post-hoc analysis 
revealed that schizophrenia patients had an increased recognition accuracy for negative 
compared to neutral images (t(38)=4.34, p<0.001) and positive compared to neutral 
images (t(38)=1.74, p<0.09), although this effect only approached significance. Healthy 
controls, on the other hand, demonstrated a superior mnemonic performance for the 
emotional relative to neutral images (Positive vs. Neutral: t(38)=4.57, p<0.001; Negative 
vs. Neutral: t(38)=2.09, p<0.043).  
fMRI results in individual groups  
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Brain activations during recognition memory of positive images (Table 2) 
Men: During the recognition memory of positively valenced images, healthy men 
activated the visual cortex, fusiform gyrus, middle and inferior temporal gyrus, 
cerebellum, superior and inferior parietal gyrus, inferior and middle frontal gyrus, the 
amygdala and hippocampus. Schizophrenia men had activations in the visual cortex,  
fusiform and inferior temporal gyrus, cerebellum, inferior parietal and postcentral gyrus, 
precuneus, middle and inferior frontal gyrus, hippocampus, amygdala and the anterior 
temporal pole.  
Women: Healthy women activated the visual cortex, fusiform gyrus, cerebellum, regions 
of the prefrontal cortex, precentral gyrus, supplementary motor area, pallidum, 
thalamus, insula and hippocampus. Women with schizophrenia activated regions of the 
visual cortex, fusiform gyrus, inferior frontal gyrus, precentral gyrus, supplementary 
motor area, hippocampus, parahippocampal gyrus and middle temporal pole.  
Brain activations during recognition memory of negative images (Table 3) 
Men: Healthy men activated the visual cortex, fusiform and inferior temporal gyrus, 
superior and inferior parietal gyrus, inferior frontal gyrus, amygdala and the 
hippocampus. Similarly, men with schizophrenia had activations in regions of the visual 
cortex, fusiform gyrus, superior and inferior parietal gyrus, inferior frontal gyrus and the 
medial orbitofrontal cortex.  
Women: During recognition memory of negative images healthy women activated the 
visual cortex, fusiform gyrus, inferior temporal gyrus, thalamus, pallidum, superior and 
inferior parietal cortex, inferior and middle frontal gyrus, inferior OFC, precentral gyrus, 
supplementary motora area, cerebellum, insula, amygdala, hippocampus and anterior 
temporal pole. Schizophrenia women activated the visual cortex, fusiform gyrus, inferior 
parietal and frontal gyrus. 
fMRI results of between group differences  
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Brain activations during recognition memory of positive images (Table 4 and 
Figure 3) 
 
Men: Schizophrenia men, in comparison to healthy men, had increased activations in 
the inferior and middle temporal gyrus, regions of the parietal cortex, the superior frontal 
and precentral gyrus, lingual gyrus, cerebellum, insula, amygdala, anterior temporal 
pole and parahippocampal gyrus.  
Women: Schizophrenia women showed decreased activity in the lingual gyrus, rolandic 
operculum, middle and inferior frontal gyrus, vermis and calcarine gyrus compared to 
healthy women.  
Brain activations during recognition memory of negative images (Table 5 and 
Figure 4) 
 
Men: Men with schizophrenia activated the medial prefrontal gyrus to a greater degree 
than healthy men. 
Women: Women with schizophrenia activated significantly fewer brain regions relative 
to healthy women including the cerebellum, thalamus, pallidum, regions of the temporal 
and visual cortex, supplementary motor area, superior parietal and precentral gyrus, 
amygdala, middle cingulated gyrus, anterior temporal pole and the hippocampus.  
Correlation analyses between cerebral activations and clinical symptoms 
 
Relationship between clinical symptoms and brain function during recognition of 
positive stimuli (Table 6) 
 
Women: We observed a negative relationship between negative symptoms and the 
brain activations associated with memory of positive images in the superior parietal 
gyrus, inferior frontal gyrus and angular gyrus. A negative relationship also surfaced 
between positive symptoms and activations in the insula. Finally, a positive correlation 
between positive symptoms and brain activations in the precentral gyrus was observed.  
Relationship between clinical symptoms and brain function during recognition of 
negative stimuli (Table 7) 
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Women: The analyses revealed a negative relationship between positive symptoms and 
cerebral activations in the left inferior frontal gyrus. Thus, the greater the positive 
symptoms in women the less the inferior frontal gyrus is activated during recognition 
memory of aversive images.  A similar negative relationship was observed between 
negative items of the PANSS and the right inferior frontal gyrus.  
Men: A significant negative correlation was observed between negative symptoms and 
brain activations in the anterior temporal pole, insula, precuneus, middle frontal gyrus, 
middle and superior temporal gyrus, cerebellum and supplementary motor area. 
Discussion  
 
We observed activations of distinct neural networks in healthy and 
schizophrenia men and women during the recognition memory of emotionally positive 
and negative stimuli. Women with schizophrenia had decreased brain activations 
relative to healthy women. In contrast, men with schizophrenia demonstrated an overall 
comparable pattern of brain activations during recognition of negative stimuli and a 
substantial increase in brain activity during the recognition of positively laden pictures 
relative to healthy men. Moreover, the correlation analysis revealed distinct 
relationships between brain function and symptoms in schizophrenia men versus 
women.  
Behavioral data 
We did not observe significant sex differences in behavior. Healthy controls and 
individuals with schizophrenia reported a comparable experience of the emotional 
pictures but the patient group had a decreased recognition accuracy of the emotional 
images relative to healthy participants. Our observation of similar subjective experience 
of emotionally laden stimuli among individuals with schizophrenia and healthy subjects 
is a well-established finding (Aghevli et al., 2003; Berenbaum & Oltmanns, 1992; Iwase 
et al., 1999; Kring et al., 1993; Kring & Moran, 2008; Kring & Neale, 1996). This finding, 
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in conjunction with the differences in the pattern of cerebral activations between 
patients and healthy subjects, provides further support for the notion of a discrepancy 
between the experience and expression of emotion in schizophrenia (Kring & Neale, 
1996; Hempel et al., 2005; Takahashi et al., 2004). Despite patient’s decreased 
performance relative to the healthy controls, the emotional memory effect was 
preserved in both groups such that more emotional than neutral pictures were 
accurately recognized. This result is consistent with previous reports that emotionally 
valenced stimuli enhance memory relative to neutral stimuli (Hamann, 2001; LaBar & 
Cabeza, 2006).    
fMRI data  
Despite comparable behavioral performances men and women with 
schizophrenia had very different pattern of brain activations during both positive and 
negative recognition memory relative to same-sex controls. Previous studies in the 
general population have observed comparable mnemonic performance between the 
sexes but qualitatively differential pattern of brain activations during emotional memory 
suggesting the use of distinct yet equally effective cognitive strategies in men and 
women (Bremner, et al., 2001; Canli, et al., 2002; Piefke, et al., 2005). It has been 
proposed that memory processing in women relies on a more detailed elaboration of 
information while memory processing in men is mainly driven by schemas or overall 
information theme (Meyers-Levy & Maheswaran, 1991; Meyers-Levy & Tybout, 1989). 
However, in the present study we did not include any means to assess the participant’s 
potential cognitive strategies during scanning and so it remains unknown if men and 
women in both groups differed regarding their strategies of encoding and generating 
responses during the memory tasks. Future studies may clarify this possibility.  
During the recognition memory of negative images, women with schizophrenia 
showed less activation compared to healthy women in an extensive network of brain 
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regions that included cortical (e.g. middle cingulate gyrus and subcortical limbic 
structures (e.g. thalamus, amygdala, hippocampus). During the positive condition, 
schizophrenia women showed decreased activity in a smaller network of brain regions 
that included the cerebellar vermis as well as the middle and inferior frontal gyrus. This 
pattern of findings mimics other studies outlining deficits in the cerebral activations 
associated with episodic memory (Achim & Lepage, 2005; Ragland et al., 2009) and the 
processing of emotion (Gur et al., 2002; Schneider et al., 1998; Takahashi, et al., 2004) 
in individuals with schizophrenia compared to healthy controls.  
Men with schizophrenia, on the other hand, showed an increase in brain 
activations compared with healthy men during positive and negative recognition 
memory. The medial prefrontal cortex, activated more in schizophrenia men relative to 
healthy men during negative recognition memory, is thought to be essential for 
mediating interactions between cognition and emotion (Gusnard et al., 2001; Ochsner 
et al., 2002; Taylor et al., 2003). Two previous functional neuroimaging studies have 
reported increased activations in the medial prefrontal cortex in patients relative to 
healthy participants during processing of emotional material (Hempel et al., 2003; 
Taylor et al., 2005). Of particular relevance, Taylor and colleagues (Taylor, et al., 2005) 
asked subjects to view aversive images selected from the IAPS collection (similar to the 
content of our task) and provide on-line subjective ratings of each image.  Similarly to 
the present results in male patients, they observed overall no group differences except 
for an increase in activation in schizophrenia participants in the left medial prefrontal 
cortex (despite comparable emotional experience). The authors put forward that activity 
in this region may play a compensatory role. Similarly, Hempel and colleagues (2003), 
in an emotion-labelling task (positive and negative emotion combined) observed an 
increase in activity in the medial prefrontal cortex in individuals with schizophrenia 
relative to healthy participants despite a significant decrease in performance. Again, the 
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authors suggested that this activity could reflect a compensatory, yet inefficient, effort 
for deficits in more basal limbic functions. 
With regards to the recognition of the positive images, men with schizophrenia 
had increased activations in comparison to healthy men in regions associated with 
emotional processing (insula, anterior temporal pole, amygdala), as well as those 
implicated more generally in episodic memory (parietal and temporal cortex). The 
lateral/posterior parietal cortex (angular, supramarginal gyrus and superior parietal 
lobule) and medial parietal cortex (precuneus) have been implicated in the successful 
retrieval of episodic memories (Cabeza et al., 2008; Davidson et al., 2008; Sestieri et 
al., 2011; Wagner et al., 2005) and have been found to be activated during successful 
recognition in individuals with schizophrenia (Lepage et al., 2010). Of relevance, the 
dorsal parietal (BA 7) and ventral parietal cortex (BA 39/40) are suggested to reflect 
top-down and bottom-up attention processes that interact closely during episodic 
memory retrieval (Cabeza, et al., 2008); and it has been suggested that activity in the 
dorsal parietal cortex increases as a function of retrieval effort  (Cabeza, 2008; Cabeza, 
et al., 2008). Although top-down attention processing may not be of primary importance 
in a simple yes/no recognition memory task, we can reason that men with 
schizophrenia, relative to healthy men, are increasing their retrieval efforts during the 
memory paradigm, albeit ineffectively in light of their inferior performance.  
Despite its prominent role in the modulation of negative emotional memories, a 
role for the amygdala in the processing of positive emotional memories has also been 
observed (Hamann et al., 1999). This region is suggested to play an important role in 
filtering, gating, and processing emotional information (Grace, 2000; Laviolette, 2007; 
Phelps, 2006). Hence, it is possible that the increased activity in the right amygdala in 
patient men reflects an impaired gating of sensory input containing emotion. Kosaka et 
al. (2002) put forth a similar interpretation when they observed exaggerated right 
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amygdala activity in patients compared to controls during recognition of positive facial 
expressions.  
The majority of studies that have observed comparable or increased cerebral 
activations in patients relative to controls during processing of emotion and episodic 
memory did not examine the neural responses in men and women separately or 
contained samples that consisted mostly of males (An et al., 2003; Crespo-Facorro et 
al., 2001; Hempel, et al., 2003; Hempel, et al., 2005; Reske et al., 2009; Sergerie, et al., 
2010; Taylor, et al., 2005). Thus, it is possible that in the above referenced studies men 
with schizophrenia exhibited less of a deficit in brain function relative to women. 
Although this notion remains highly speculative due to the clinical heterogeneity of 
tested patients, the differences in the task and stimuli used among studies and of 
course the lack of investigation of sex differences; it is reinforced by our previous work 
in which we observed an increase in brain function in patients relative to healthy 
controls during the recognition memory of positive images using overall the same 
patient sample as the present study (Lakis, et al., 2011).  Specifically, our current 
findings show that it is men and not women with schizophrenia who were driving this 
increase in neural activity.  
Despite aforementioned sex differences in the pattern of cerebral activations 
both men and women with schizophrenia failed to activate limbic areas, including the 
amygdala and hippocampus, during recognition of negative images. Two prominent 
negative emotions, fear and anger, have been shown to be particularly salient for 
individuals with schizophrenia (Mandal et al., 1998) and the neuroimaging literature 
supports the notion that abnormal amygdala and hippocampal functioning together with 
other regions that play an important role in the modulation of affect and emotional 
memories may be responsible for impaired emotion processing (particularly the 
perception of fear) in individuals with schizophrenia (Paradiso et al., 2003; Phillips, et 
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al., 2003; Phillips, et al., 1999; Russell et al., 2007; Schneider, et al., 1998; Takahashi, 
et al., 2004; Williams et al., 2004). In line with this idea, our current findings show that 
the overall inability to activate limbic and paralimbic areas in men and women with 
schizophrenia may be specific to negative emotion processing. 
In addition to qualitative differences in the pattern of cerebral activations in men 
and women with schizophrenia, our results provide new evidence of different 
relationships in men and women between brain function associated with emotional 
recognition memory and specific symptomatology. We observed an inverse correlation 
between limbic regions (e.g. insula, anterior temporal pole, cerebellum) and negative 
symptoms only in men during recognition of negative pictures. The literature concerning 
the relationship between negative symptoms and activations in limbic areas has been 
somewhat inconsistent. For instance, an inverse relationship (Mendrek, et al., 2010 ), a 
positive relationship (Gur et al., 2007) or no significant correlation between negative 
symptoms and brain function during processing of unpleasant stimuli (Takahashi, et al., 
2004), have been demonstrated.  
Contrary to our expectations, we did not observe a significant relationship 
between positive symptoms and subcortical limbic structures activations in women. 
Nonetheless, an inverse correlation between activity in the insula and positive 
symptoms was present in women during recognition of positive images. The association 
of positive symptoms with activation in limbic regions during processing of emotional 
stimuli in individuals with schizophrenia has been previously reported. However, in 
these studies an association with psychotic symptoms (in particular paranoia) and 
overactivity of limbic regions (particularly the amygdala) during processing of 
threatening/aversive stimuli was reported (Phillips, et al., 1999; Taylor et al., 2002). 
Although not a subcortical limbic structure, the insula has afferent and efferent 
connections with the amygdala and other limbic regions that include the medial and 
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orbitofrontal cortices and anterior cingulate gyrus (Augustine, 1996). Activity in the 
insula has been associated with successful retrieval of items from emotional contexts 
(Hamann, 2001; LaBar & Cabeza, 2006), with internally generated recalled emotions 
and with cognitively demanding emotional tasks (Phan, et al., 2002). It should be 
mentioned that the patient sample recruited for this study were in a stable phase of their 
illness and so it is possible that there is insufficient variation in the positive symptoms of 
participants with schizophrenia to show a clear correlation with subcortical limbic 
structures. Examination of a more symptomatic group of patients could clarify this point.  
 In line with our hypotheses, we observed a negative correlation between 
negative symptoms and prefrontal cortex activation in men (during recognition of 
negative images) and women (during recognition of both negative and positive images). 
The inverse relationship between the presence of negative symptoms and prefrontal 
cortex activation is consistent with the findings of other studies indicating that negative 
symptoms of schizophrenia are related with “hypofrontality” (Semkovska et al., 2001; 
Weinberger & Berman, 1996). Likewise, we have previously noted an inverse 
relationship between the presence of negative symptoms and prefrontal cortex 
activation during the processing of sadness-inducing images in individuals with 
schizophrenia (Mendrek, et al., 2010 ). Overall, the correlation data show that the 
degree with which clinical symptoms are associated with cerebral activations during 
emotional recognition memory in men versus women depends on the valence of the 
presented stimuli, but more studies are needed in this area. 
We would like to acknowledge that the interpretation of the present study is 
limited by the fact that old and new images were randomly intermixed within each block, 
and so cerebral activations associated with only correct retrieval of stimuli into memory 
could not be ascertained. Because of this, it is possible that other processes, rather 
than simply recognition, could have affected the pattern of cerebral activations; as such 
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our data more likely reflect an attempted retrieval process. Also, despite the fact that 
brain activity in response to new stimuli and old stimuli were not differentiated, both 
healthy controls and patients with schizophrenia (though to a lesser extent) 
demonstrated accuracy significantly above chance level, indicating that an accurate 
recognition process was taking place.  
To conclude, we observed that the degree with which individuals with 
schizophrenia show an atypical pattern of activations in limbic, prefrontal and parietal 
regions during recognition of emotional pictures compared with healthy controls 
depends on whether the individual is male or female and depends, to a certain extent, 
on the valence of the presented stimuli. These findings, in conjunction with past 
functional neuroimaging literature (Guillem, et al., 2009; Jiménez, et al., 2010; Mendrek, 
et al., 2010 ; Mendrek, et al., 2007; Mendrek, 2009) demonstrate the importance of 
investigating men and women with schizophrenia separately in the context of emotional 
and cognitive tasks. 
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Table/Figure legends 
 
Figure 1. Subjective ratings in schizophrenia and healthy men and women 
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
 
Bars represent standard error of the mean 
 
Figure 2. Recognition accuracy in schizophrenia and healthy men and women 
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
 
Bars represent standard error of the mean 
 
Figure 3. Cerebral activations associated with the recognition of positive images 
in schizophrenia and healthy men and women.  
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
 
The colored bar represents the range of z-scores of the cerebral activations with 
significance increasing from light blue to orange.  
 
Figure 4. Cerebral activations associated with the recognition of negative images 
in schizophrenia and healthy men and women.  
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
 
The colored bar represents the range of z-scores of the cerebral activations with 
significance increasing from light blue to orange.  
 
Table 1. Demographic and clinical characteristics of schizophrenia and healthy 
men and women. 
SES = Socioeconomic status 
SD=Standard deviation in parentheses 
* = Significant p<0.05 between men and women 
 
Table 2. Cerebral activations associated with the recognition of positive images 
in schizophrenia and healthy men and women.  
 
* = Brain region is part of the same cluster 
OFC=orbitofrontal cortex 
SMA=Supplementary motor area 
BA=Brodmann area; L/R=Left/Right 
 
Table 3. Cerebral activations associated with the recognition of negative images 
in schizophrenia and healthy men and women.  
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* = Brain region is part of the same cluster 
OFC=orbitofrontal cortex 
SMA=Supplementary motor area 
BA=Brodmann area; L/R=Left/Right 
 
Table 4. Direct comparisons between groups of the same sex during recognition 
of positive images in schizophrenia and healthy men and women. 
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
* = Brain region is part of the same cluster 
BA=Brodmann area; L/R=Left/Right 
 
Table 5. Direct comparisons between groups of the same sex during recognition 
of negative images in schizophrenia and healthy men and women. 
 
HM=Healthy men, HW=Healthy women, SZ-M=Schizophrenia men, SZ-
W=Schizophrenia women 
SMA=Supplementary motor area 
* = Brain region is part of the same cluster 
BA=Brodmann area; L/R=Left/Right 
 
Table 6. Correlations between brain activations and recognition memory of 
positive images in schizophrenia men and women 
 
SZ-W=Schizophrenia women 
BA=Brodmann area; L/R=Left/Right 
 
Table 7. Correlations between brain activations and recognition memory of 
negative images in schizophrenia men and women 
 
SZ-M=Schizophrenia men, SZ-W=Schizophrenia women 
SMA=Supplementary motor area 
BA=Brodmann area; L/R=Left/Right 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Table 1. Demographic and clinical characteristics of men and women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Subjects with schizophrenia Normal control subjects  
Women (N= 20) Men (N= 21) Women (N= 
19) 
Men (N= 22) 
Age (years) 32.75 (6.37) 31.09 (7.42) 31.89 (8.86) 30.54 (7.81) 
Parental SES 2.57 (1.06) 2.76 (0.75) 2.05 (1.11) 2.43 (1.11) 
Handedness, No. right  (%) 20 (89.37) 17 (59.4) 18 (68.36) 18 (54.36) 
Age at onset (mean and SD) 24.55 (6.17) 20 (3.58) *   
Duration of Illness years (mean 
and SD) 
8.2 (5.8) 11 (7.83)   
Chlorpromazine equivalents, mg 473.33 (306.9) 711.90 (377.16) *   
PANSS positive 19.80 (7.85) 18.14 (5.64)   
PANSS negative 21.2 (8.37) 19.52 (4.87)   
PANSS general 43.15 (12.85) 39.38 (6.16)   
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Table 2. Brain activations during recognition of positive images 
Anatomical area L/R 
Healthy women Schizophrenia women 
BA MNI coordinates 
Z-
scor
e 
Voxel
s BA 
MNI 
coordinates 
Z-
scor
e 
Voxel
s x y z x y z 
Fusiform gyrus L 19 -28 -66 -14 5.34 5616 37 -35 -60 -14 6.30 4115 
 R 37 35 -52 -18 5.63 * 37 32 -49 -18 6.33 * 
Lingual gyrus L 18 -4 -80 -10 5.64 * 18 -21 -80 -10 6.73 * 
Superior occipital R 18 10 -98 18 5.63 * 7 28 -66 38 3.87 * 
Calcarine L 17 -7 -91 -4 5.46 * 17 -10 -88 -7 6.74 * 
Middle occipital L 18 -14 -102 4 5.06 * 19 -24 -91 7 5.98 * 
 R 19 32 -77 28 3.79 * 18 24 -91 4 7.01 * 
Cerebellum  L - -28 -60 -58 3.51 21       
Hippocampus  L - -21 -21 -14 3.49 49 - -21 -28 -7 3.64 76 
 R - 21 -28 -7 3.12 10 - 21 -28 -4 3.73 110 
Parahippocampal gyrus L       28 -18 -28 -14 3.70 100 
Middle temporal pole R       38 35 7 -32 3.25 7 
Inferior frontal R 9 60 14 32 4.35 490 9 42 7 24 4.13 178 
Middle frontal R 6 49 -4 52 4.06 *       
Inferior OFC R 47 35 32 -7 3.55 *       
Insula R 47 38 28 -4 3.48 *       
Inferior frontal L 46 -52 28 24 3.83 128       
Precentral gyrus L 6 -49 0 35 3.28 22 9 -42 4 35 4.04 74 
Inferior OFC L 47 -38 32 -18 3.74 83       
SMA L 6 -4 -7 56 3.36 90 6 -4 7 56 3.45 18 
 R 6 10 7 70 3.75 *       
Superior medial frontal L 10 -10 63 32 3.47 11       
 R 8 4  35 57 3.29 8       
Pallidum L - -21 0 4 3.22 15       
Thalamus R - 21 -28 -4 3.12 10       
  Healthy men Schizophrenia men 
Middle occipital L 17 -18 -94 -4 7.72 5006       
 R 18 28 -88 0 7.19 * 19 28 -88 14 5.43 4995 
Calcarine L       17 7 -94 0 6.66 * 
 R 17 14 -94 4 7.39 *       
Fusiform L 19 -35 -70 -14 7.23 * 19 -32 -74 -18 5.57 * 
 R 19 35 -63 -18 7.16 * 20 35 -38 -24 6.25 * 
Lingual L        30 -14 -32 -4 4 * 
 R 17 24 -91 -4 7.10 * 18 10 -84 -14 6.23 * 
Inferior occipital L       19 -35 -80 -7 5.54 * 
 R 18 32 -84 -4 7.04 *       
Cuneus L       19 -7 -94 28 4.47 * 
 R       19 10 -91 28 5.02 * 
Middle temporal L 37 -46 -70 7 6.2 *       
Inferior temporal R 37 49 -63 -4 6 * 21 42 -4 -32 3.83 20 
Cerebellum L - -7 -74 -32 5.26 * - -10 -84 -18 5.76 * 
 R - 7 -70 -35 4.75 *       
Superior parietal L 7 -24 -56 42 5.21 *       
Inferior parietal L 40 -46 -38 46 3.80 8 40 -46 -42 52 3.95 56 
Postcentral gyrus L       2 -49 -24 49 4.11 * 
Precuneus R       7 4 -70 38 3.84 * 
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Hippocampus L - -24 -28 -6 4.82 98 - -18 -28 -7 4 12 
 R - 24 -28 -6 4.98 71 - 18 -32 -4 4.14 72 
Amygdala L - -24 -7 -12 4.61 42 - -21 0 -21 3.74 5 
 R       - 28 4 -28 3.83 15 
Anterior temporal pole L       28 -28 7 -24 3.74 8 
Inferior frontal L 44 -46 10 24 5.78 219       
 R 9 52 14 32 6.42 392 9 49 7 28 3.92 18 
Middle frontal R 6 38 -4 52 4.20 29 6 38 -7 52 3.90 5 
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Table 3. Brain activations during recognition of negative images 
Anatomical area L/R 
Healthy women Schizophrenia women 
BA MNI coordinates 
Z-
scor
e 
Voxel
s BA 
MNI 
coordinates 
Z-
scor
e 
Voxel
s x y z x y z 
Middle occipital gyrus L 19 -42 -84 10 6.47 7995 19 -24 -91 7 5 2976 
 R 39 42 -77 14 6.43 * 18 32 -84 0 5.65 * 
Inferior occipital gyrus L       19 -38 -66 -10 5.84 * 
 R 18 46 -80 -10 6.28 *       
Calcarine fissure L 17 -7 -91 -7 5.82 * 18 4 -84 -4 5.85 * 
Cuneus R 18 10 -98 18 5.72 *       
Inferior temporal  R 37 49 -63 -10 5.79 *       
Fusiform L 19 -32 -66 -14 5.70 * 37 -38 -56 -14 5.75 * 
 R 37 42 -49 -18 5.77 * 10 38 66 -14 5.73 * 
Lingual gyrus R 18 7 -84 -7 5.65 * 18 18 -80 -14 5.97 * 
Thalamus L - -14 -10 0 3.68 *       
Pallidum R - 24 -11 -4 3.69 *       
Superior parietal L 7 -10 -84 49 5.19 *       
Inferior parietal L 7 -28 -56 52 4.26 * 40 -35 -42 42 3.61 32 
Inferior OFC L 47 -38 32 -18 3.48 22       
Inferior frontal L 45 -46 24 18 3.69 347       
Middle frontal L 9 -56 18 35 3.37 *       
Precentral L 20 -35 -7 -46 3.56 *       
Inferior frontal gyrus R 46 52 21 24 5.15 721 9 46 7 28 3.32 6 
Middle frontal R 6 49 -4 52 3.81 *       
Precentral R 9 42 4 32 4.84 *       
Insula R 47 38 28 -4 3.75 *       
SMA R 6 7 10 52 3.55 170       
Superior frontal R 6 18 4 74 3.46 *       
Hippocampus L - -32 -7 -28 3.53 49       
Amygdala L - -24 0 -18 3.20 26       
 R - 28 0 -28 3.11 10       
Anterior temporal pole L 38 -32 10 -24 3.03 63       
Insula L 13 -32 24 0 3.04 7       
Cerebellum L - -21 -32 -46 3.19 12       
  Healthy men Schizophrenia men 
Fusiform gyrus L 37 -35 -63 -10 6.85 4165 37 -35 -60 -21 5.29 3701 
 R 37 42 -49 -18 7.8 * 37 32 -49 -21 5.54 * 
Inferior temporal gyrus R 37 42 -63 -10 7.33 * 37 42 -60 -10 5.51 * 
Middle occipital L 19 -24 -91 4 5.94 * 19  -35 -84 0 5.24 * 
 R 39 42 -77 14 6.31 * 19 42 -74 4 4.78 * 
Inferior occipital L 19 -42 -74 -10 6.34 * 19 -35 -80 -10 5.18 * 
 R 19 42 -74 -4 6.85 * 19 35 -74 -4 5.34 * 
Superior occipital R       19 14 -98 24 5.67 * 
Calcarine gyrus R 17 10 -94 0 6.64 * 17 10 -94 4 5.81 * 
Cuneus R 18 14 -98 7 6.54 * 18 21 -94 10 5.59 * 
Lingual gyrus R 18 7 -84 -7 6.53 * 18 14 -56 4 3.87 * 
Superior parietal R 7 28 -60 49 4.53 * 7 28 -70 52 3.46 39 
Inferior parietal L 7 -28 -52 46 4.73 45 40 -35 -42 42 4.24 41 
Amygdala L - -28 0 -18 4.63 28       
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 R - 32 -2 -14 4.09 12       
Hippocampus L - -14 -28 -10 4.68 48       
 R - 21 -32 -7 5.20 97       
Inferior frontal L 9 -42 14 28 5.20 222 46 -46 18 24 3.24 5 
 R 9 46 14 24 5.63 209 9 49 7 28 3.29 12 
Medial OFC L       11 -4 52 -14 3.63 5 
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Table 4. Direct comparisons between groups of the same sex during recognition of 
positive images in schizophrenia and healthy men and women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anatomical area L/R 
HW greater than SZ-W 
BA MNI coordinates Z-score Voxels x y z 
Lingual gyrus L 18 -10 -74 -10 3.15 29 
Rolandic operculum R 6 60 0 7 3.04 16 
Middle frontal R 8 52 14 42 2.89 16 
Vermis R - 0 -63 -42 2.73 9 
Inferior frontal L 46 -52 28 21 2.71 6 
Calcarine L 23 -4 -77 10 2.66 9 
  SZ-M greater than HM 
Inferior temporal  R 20 46 -4 -32 3.85 1132 
Middle temporal R 21 52 4 -32 3.81 * 
Precuneus L 7 -4 -63 42 3.69 728 
 R 7 7 -56 42 3.57 * 
Postcentral  R 3 24 -38 60 3.40 * 
Postcentral gyrus L 6 -60 -4 35 3.55 71 
Precentral L 4 -52 -7 46 3.13 * 
 R 6 32 -14 49 3.35 135 
Superior frontal  R 24 21 -4 52 2.91 * 
Angular gyrus L 40 -38 -49 32 2.81 20 
Inferior parietal L 40 -49 -42 38 2.66 * 
Angular gyrus R 39 46 -63 28 3.24 42 
Lingual L 18 -10 -52 -4 2.96 55 
Cerebellum L - -10 -60 -21 2.83 * 
 R - 38 -56 -52 2.88 10 
Anterior temporal pole L 28 -32 4 -28 2.92 11 
Parahippocampal 
gyrus 
L 36 -24 -35 -14 2.90 41 
Inferior temporal L 36 -35 -32 -14 2.70 * 
Amygdala R - 32 0 -28 3.09 33 
Insula L 13 -38 -10 21 2.75 5 
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Table 5. Direct comparisons between groups of the same sex during recognition of 
negative images in schizophrenia and healthy men and women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anatomical area L/R 
HW greater than SZ-W 
BA MNI coordinates Z-score Voxels x y z 
Cerebellum L - -35 -56 49 3.84 1926 
thalamus L - -14 -7 4 3.79 * 
pallidum R - 24 -10 4 3.75 * 
Inferior temporal   R 37 46 -52 -18 3.04 * 
Inferior temporal   L 36 -42 -38 -10 2.92 13 
Superior temporal L 41 -42 -38 10 3.08 21 
calacarine L 18 0 -74 14 3.62 204 
Cuneus R 31 21 -70 21 2.99 * 
Middle occipital R 19 35 -74 7 2.86 13 
Amygdala R - 32 -4 -28 3.53 35 
Middle temporal gyrus R 21 46 0 -28 3.01 69 
Middle cingulum L 24 -7 -7 46 3.14 104 
 R 24 7 -10 49 2.95 * 
SMA R 24 4 -4 46 3.01 * 
Superior temporal pole  L 38 -35 10 -24 2.92 30 
Hippocampus  L - -32 -4 -28 2.79 25 
Superior parietal L 7 -21 -52 52 3.04 23 
Precentral  R 9 52 7 38 2.89 21 
Lingual   L 18 -10 -52 -4 2.74 8 
  SZ-M greater than HM 
Medial prefrontal gyrus L 10 -7 56 0 3.25 28 
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Table 6. Correlations between brain activations and recognition memory of positive 
images in schizophrenia men and women 
 
 
 
 
Table 7. Correlations between brain activations and recognition memory of negative 
images in schizophrenia men and women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive Emotion L/R BA Anitomical area MNI coordinates Z-score Voxels x y z 
SZ-W Negative correlation – Negative symptoms 
 L 7 Superior parietal gyrus -21 -56 42 3.44 39 
 R 9 Inferior frontal gyrus 32 7 28 3.11 24 
 L 9 Inferior frontal gyrus -42 4 24 2.95 8 
 R 7 Angular gyrus 24 -60 42 3.00 10 
 Positive correlation – Negative symptoms 
 R 4 Precentral gyrus 35 -24 49 3.07 23 
 Negative correlation – Positive symptoms 
 R 13 Insula 32 24 7 3.04 12 
Negative Emotion L/R BA Anitomical area MNI coordinates Z-score Voxels x y z 
SZ-M Negative correlation – Negative symptoms 
 R 38 Anterior temporal pole 52 4 -7 3.73 301 
 R 22 Insula 49 -4 0 3.57 * 
 R 41 Superior temporal gyrus 56 -24 10 3.08 * 
 R 7 Precuneus 7 -46 60 3.33 171 
 L 21 Middle temporal gyrus -63 -24 -4 3.26 64 
 R 9 Middle frontal gyrus 28 49 35 3.17 74 
 R - Cerebellum 7 -77 -46 3.02 71 
 L - Cerebellum -18 -70 -52 3.00 * 
 R 6 SMA 4 -18 63 3.01 72 
 L 8 Middle frontal gyrus -28 35 42 3.02 8 
SZ-W R 46 Inferior frontal gyrus 52 38 10 3.10 15 
SZ-W Negative correlation – Positive symptoms 
 L 46 Inferior frontal gyrus -49 42 13 2.98 8 
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V. General Discussion 
The research documented in this thesis is the first to: (1) examine the neural 
correlates of emotional recognition memory of stimuli that differed in both valence 
(positive vs. negative) and arousal (high vs. low) in individuals with schizophrenia and 
(2) to reveal distinct pattern of brain activations associated with emotional recognition 
memory in men and women with schizophrenia. 
              In the first study, we observed that, relative to healthy controls, individuals with 
schizophrenia had a similar pattern of brain activations during the recognition of highly 
arousing positive and neutral images and decreased brain activations during the 
recognition of negative pictures. This was observed despite an overall inferior 
recognition memory performance in patients with schizophrenia compared with healthy 
controls. Moreover, patients with schizophrenia resembled healthy controls such that 
both groups showed increased brain activations during the recognition of high relative to 
low arousing images, which paralleled the comparable subjective ratings of the 
emotional stimuli in both groups. 
In the second study, we uncovered sex differences in the cerebral activations 
associated with the recognition memory of positively and negatively valenced pictures. 
Specifically, men with schizophrenia demonstrated an increased pattern of brain 
function compared to healthy men while women with schizophrenia showed decreased 
activations relative to their healthy same-sex counterparts. Interestingly, the extent of 
sex differences within groups of the same sex (e.g. healthy men vs. schizophrenia men) 
depended on the valence of the presented stimuli. For instance, men with schizophrenia 
activated an extensive network of brain regions encompassing regions of the limbic, 
parietal and temporal cortex in the positive condition compared to healthy men, but only 
activated the medial prefrontal gyrus to a greater degree than healthy men during the 
negative condition. In addition, we observed that clinical symptoms were significantly 
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associated with brain function during positive emotional memory in women and during 
negative emotional memory primarily in men. These findings suggest that the degree 
with which clinical symptoms are associated with cerebral activations during emotional 
recognition memory in men versus women depends on the valence of the presented 
stimuli. 
The numerous studies that have investigated the processing of emotional 
material and episodic memory in individuals with schizophrenia have generally reported 
a pattern of decreased cerebral activations relative to healthy subjects in several 
regions implicated in affect (e.g., hippocampus, amygdala, medial prefrontal, 
orbitofrontal cortex, and cingulate cortices) and episodic memory (e.g. parietal, 
prefrontal cortex) (Achim & Lepage, 2005; Gur, et al., 2002; Schneider, et al., 1998; 
Takahashi, et al., 2004). Others, however, have observed either an increased or a 
similar pattern of cerebral activations between both groups (Crespo-Facorro et al., 
2001; Dowd & Barch, 2010; Kosaka et al., 2002; Reske et al., 2009; Zierhut et al., 
2010). It is clear that the lack of straightforward findings in emotion, episodic memory 
and more recently emotional episodic memory studies cannot easily be reconciled. 
However, based on the findings of meta-analyses investigating both emotion and 
memory processing in schizophrenia, the general consensus is that patients with 
schizophrenia present with a decreased pattern of brain function compared with 
controls (Achim & Lepage, 2005; Li et al., 2010). Interestingly, the findings of our first 
study illustrate that the extent with which individuals with schizophrenia activate or 
deactivate neural networks during the processing of emotional memory depends both 
on the valence and arousal levels of presented stimuli. To date, several studies have 
focused solely on investigating the processing of negative emotion in schizophrenia 
perhaps because, despite a general impairment in the perception of emotion, 
individuals with schizophrenia are highly sensitive to certain negative emotions of fear 
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and anger (Mandal et al., 1998). Of the studies that have included both negative and 
positive stimuli, arousal levels across emotional valence categories were often not 
equated or the analysis of high vs. low arousing stimuli was not investigated. Hence, it 
is possible that when stimuli are appropriately matched in terms of arousal, the positive 
stimuli, relative to negative, elicit more cerebral activations, especially for highly 
arousing images (which is where our most robust finding came from).  
The findings of our second study further demonstrated that the degree with 
which  patients with schizophrenia show deficits in brain activations during the 
recognition of emotional memories depends on whether the patient is male or female. 
For instance, of the studies that have observed comparable or increased cerebral 
activations in patients relative to controls during processing of emotion and memory, 
very few have included women and, even when they did, the sample sizes were 
typically too small to allow for examination of sex differences (An et al., 2003; Crespo-
Facorro, et al., 2001; Hempel et al., 2003; Hempel et al., 2005; Reske, et al., 2009; 
Sergerie, et al., 2010; Taylor et al., 2005). Thus, it is possible that in the above 
referenced studies men with schizophrenia exhibited less of a deficit in brain function 
relative to women (as was observed in our second study). Although this notion is 
tentative due to the clinical heterogeneity of tested patients, as well as differences in the 
task and stimuli used among studies and of course the lack of investigation of sex 
differences; it is reinforced by our first study in which we observed an increase in brain 
function in patients relative to healthy controls during the recognition memory of high 
arousal positive and neutral images using overall the same patient sample (Lakis et al., 
2011).  Specifically, our second study illustrates that the increased neural activation is 
largely driven by male patients. 
Valence and arousal are generally treated as independent factors, but real-world 
experience and laboratory studies (including our own) suggest that they often interact 
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with one another (Canli, et al., 2002; Hall, et al., 2007; Lane et al., 1999). Unfortunately, 
few studies have systematically investigated the interaction between arousal and 
valence as well as investigating sex differences. Our research group has recently taken 
strides in this area by uncovering sex differences in healthy participants, mediated by 
both valence and arousal, in the ERP responses associated with emotional episodic 
memory (Glaser et al., 2012). Bearing this in mind, an analysis of sex differences in 
patients with schizophrenia using stimuli that differ in both valence and arousal in the 
context of an emotional memory paradigm warrants further attention. Combined, the 
results of the present thesis emphasize the importance of taking the affective valence 
and arousal levels of emotional stimuli as well as the sex of tested individuals into 
account when designing experimental tasks focusing on the interaction between 
cognition and emotion. 
Differences in the cognitive strategies used during the encoding and/or 
recognition of emotional information may have contributed to the observed group and 
sex-specific differences during performance of the emotional memory paradigm. Some 
studies have observed that individuals with schizophrenia are just as likely as healthy 
controls to spontaneously use encoding strategies facilitating the retrieval of verbal 
stimuli (Kirchhoff, 2009). However, most studies have found that patients with 
schizophrenia fail to generate effective mnemonic strategies during the encoding and 
subsequent retrieval of information into memory (Iddon et al., 1998; Koh, 1978) but 
when prompted to use strategies that incite deep semantic processing of certain stimuli, 
they show an enhancement in memory performance (Bonner-Jackson, et al., 2005; Koh 
& Peterson, 1978; Ragland et al., 2005; Ragland et al., 2003). This effect is reportedly 
greater during the incidental encoding of material into memory (Bonner-Jackson et al., 
2008). Further, the results of Bonner-Jackson and colleagues (2008) show that when 
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memory strategies are provided, patients with schizophrenia activate the same neural 
systems implicated in memory formation as healthy controls. 
With regards to the general population, some studies suggest the existence of 
differences in the way men and women process information and in the cognitive 
strategies used to retrieve this information from memory. For instance, it has been 
hypothesized that males employ a schema-based strategy to assess recognition while 
females exhibit a greater tendency to engage in elaborate and detailed message 
processing and hence employ a detailed strategy during recognition (Meyers-Levy & 
Maheswaran, 1991; Meyers-Levy & Sternthal, 1991). Likewise, Fujita and colleagues 
(1991) have proposed the “affect-intensity” hypothesis, which suggests that women 
have a superior memory compared to men because they experience life events with a 
greater intensity and therefore more deeply encode such events into memory. Thus, 
according to the view of Fujita et al. (1991), women will have a similar pattern of 
cerebral activations during the recognition of emotional stimuli but to a greater degree 
than men. In contrast, if the subjective emotional experience of the presented stimuli is 
comparable between the sexes, the superior mnemonic performance in women would 
disappear and there would be no significant difference in the pattern of brain function. 
Subsequently, Seidlitz and Diener (1998) came forth with the “cognitive-style” 
hypothesis and postulated that men and women differ in their way of encoding, 
rehearsing and thinking about emotional experiences that will ultimately lead to 
differences in performance and to qualitatively distinct patterns of cerebral activations 
during the processing of emotional episodic memories. In addition, this view implies that 
any sex-specific difference in memory performance or brain activations will persist even 
if the subjective emotional experience of the presented stimuli is comparable between 
the sexes. Taking into consideration the qualitatively different pattern of brain 
activations that we observed in both healthy and schizophrenia men and women as well 
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as the comparable subjective emotional experience of the presented affective pictures 
observed between the sexes, we believe that the results of the current thesis fall in line 
with the “cognitive-style” hypothesis. Moreover, the sex differences in cerebral function 
in conjunction with the lack of sex differences in recognition accuracy may indicate the 
use of distinct yet equally effective cognitive strategies in men and women– a notion 
that has been proposed by previous studies with a similar pattern of findings (Bremner 
et al., 2001; Canli, et al., 2002; Piefke, et al., 2005).  Our experimental memory task 
was designed in such a way that participants were not instructed to try and remember 
the pictures presented during encoding but they were still aware that they were going to 
undergo a subsequent memory task. Hence, following the literature in the healthy 
population, it is possible that men and women in our patient group differed in their 
tendency to instinctively generate encoding strategies and in their ability to effectively 
use such strategies. This is especially intriguing in light of recent reports that, despite 
similar error scores between male and female schizophrenia-spectrum patients during 
performance of a working memory task, men and women differed with regards to the 
cognitive strategy used to manage the task (Lecardeur et al., 2010). Albeit not an 
emotional memory task, these findings suggest that differences between women and 
men could be missed if behavior alone is taken into account. Thus, examining strategy 
use during cognitive tasks is necessary to better understand differences between 
females and males throughout task performance (Lecardeur & Mendrek, 2012). It is 
important to mention that the design of the present study did not allow us to ascertain 
the participant’s potential cognitive strategies during scanning and so it remains unclear 
how this could have influenced brain and behavioral performance during the recognition 
task. Future studies that implement qualitative comparisons between the encoding and 
retrieval strategies used by men and women would clarify this possibility. 
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Another important factor to take into consideration when interpreting the results 
of the present thesis is that both old and new images were randomly intermixed within 
each block and so cerebral activations associated with only correct retrieval of stimuli 
into memory could not be ascertained. Because of this feature of the experimental 
design, it is possible that other processes, rather than simply recognition, could have 
affected the pattern of cerebral activations observed, which is indicative that our data 
more likely reflected an attempted retrieval process. Of the very few studies that have 
investigated the neural correlates of emotional episodic memory in schizophrenia, none 
have examined the brain regions activated during the retrieval of old (or already seen) 
stimuli into memory. For instance, Whalley and colleagues (2009) implemented a 
design in which accurate recognition accuracy was correlated with cerebral activations 
during the encoding of emotional information into memory. In contrast, Sergerie et al. 
(2010) did analyze their functional data with the contrast of subjective old (i.e. hits and 
false alarms) minus subjective new (i.e. misses and correct rejections) for sad and 
happy facial expressions but only reported the brain regions that correlated significantly 
with behavioral response bias. Disentangling the cerebral activity associated with 
correct and incorrect recognition memory makes it possible to extricate the effects of 
emotion on brain activations during the process of retrieval versus successful retrieval. 
Hence, it would be possible to delineate the neural networks involved in the process, 
separate from the success, of a retrieval attempt. It is worth noting that healthy controls 
and patients with schizophrenia who participated in this study also underwent an event-
related potential session while performing the same emotional memory paradigm. This 
was done to observe brain function associated with memory of emotional stimuli with an 
increased temporal resolution but also to allow us to explore cerebral function 
associated with correct versus incorrect recognition of emotional images into memory. 
We are currently in the process of exploring this data. 
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Regarding the existence of sex differences in the overall expression of 
schizophrenia, the bulk of studies have suggested that differences in the development 
of the brain between men and women, controlled by the influence of sex steroid 
hormones and genetic factors, forms the foundation of sex differences in the behavior, 
performance and expression of schizophrenia (Abel, et al., 2010; Hafner, et al., 1998; 
Mendrek, 2007; Seeman & Lang, 1990). The development of a male or female brain 
depends on the type of circulating hormone and the level of hormonal activity present 
during the development of the embryo in the womb. More specifically, the presence of 
testosterone influences a “male” brain to mature during early development while the 
lack of androgens will permit a “female” brain to develop through a passive mechanism 
by default (Zaidi, 2010). Still, studies have demonstrated that estrogen does in fact play 
an active role in the differentiation of the female brain and that this occurs at a later time 
period than testosterone-related processes (Dohler, 1991; Dohler et al., 1984). Also of 
relevance, there exists evidence of several brain regions implicated in emotion and 
cognition (e.g. amygdala, hippocampus and cerebellum) that are altered during brain 
development due to sex steroid hormones (Dean & McCarthy, 2008; Galea et al., 2006) 
and so it is not unexpected that functional neuroimaging studies have outlined 
differences between men and women during performance of emotional and cognitive 
tasks. Thus, differences between male and female patients with schizophrenia may be 
caused, at least in part, by the normal sexual dimorphism of the brain, due to which 
men and women differentially recruit brain regions to perform certain cognitive and 
emotional tasks. On the other hand, because of the effect of sex steroid hormones on 
region-specific differentiation of the brain during prenatal and perinatal periods, a 
differential vulnerability of male and female brains to early, schizophrenia predisposing 
brain lesions may take place (Leung and Chue, 2000). Interestingly, the slower rate of 
development of the male brain may make it more susceptible to early brain insults 
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contributing to a more severe form of the illness in men compared to women (Hafner, 
2003). Of note, a particularly strong argument has been made regarding the 
organizational/structural and activational/functional effects of estrogen in providing a 
protective mechanism for women with schizophrenia in the development of the disorder 
and accounting for sex differences in schizophrenia (Leung & Chue, 2000; Seeman, 
1996, 1997; Seeman & Lang, 1990).  
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VI. Conclusion 
This thesis illustrates that the affective valence and degree of arousal of 
presented stimuli is important to take into account when investigating episodic memory 
in patients with schizophrenia. Another important variable is the sex of tested individuals 
since a multitude of studies in the general population, and in the schizophrenia 
population (albeit less frequently), have outlined significant differences between men 
and women in the brain activations associated with emotional and cognitive tasks 
(Domes et al., 2010; Gur, R. C. et al., 2000; Koch et al., 2007; Wager et al., 2003; 
Weiss et al., 2003). Our research has the potential to make an important contribution to 
the understanding of emotional episodic memory in schizophrenia as well as sex 
differences in the brains of patients with schizophrenia, which will further contribute to 
the advancement of the basic mechanisms of emotional memory in this population (a 
feat that is underexplored thus far in the literature). Moreover, the results of the present 
research, as well as the findings of other research endeavors investigating differences 
between men and women with schizophrenia, have the potential to influence future 
development of sex-based clinical interventions for schizophrenia (e.g. at the level of 
antipsychotic medication use, psychosocial and cognitive remediation therapy). For 
instance, at the molecular level and regardless of sex, advances in individualized 
therapy are already being made. Specifically, the field of pharmacogenomics aims to 
select drugs with the greatest chance of benefit and the least likelihood of harm in 
individual patients based on their genetic make-up, i.e., individualized therapy (Basile et 
al., 2002). Considering this, it is also important to keep in mind that biological 
differences between males and females also contribute substantially to disease 
susceptibility and males and female may have a different spectrum of genetic variants 
underlying disease, which could in turn affect treatment response and outcome 
(Pinsonneault and Sadee, 2003).  Unfortunately, the majority of schizophrenia research 
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combines men and women into one experimental group or consist primarily of all male 
samples. Also, psychiatric services for patients with schizophrenia are usually 
developed for men, as the archetypal patient with schizophrenia is male. However, male 
and female patients with schizophrenia have clear and obvious differences in the way 
their brains function during important cognitive and emotional tasks (as was observed in 
our research) that are (1) highly impaired in schizophrenia and (2) relevant for everyday 
social functioning, so why should they be given the same clinical treatments? Although 
the possibility of sex-specific treatment in schizophrenia is intriguing it remains highly 
speculative due to the lack of research initiatives that take sex as a relevant covariate of 
interest when exploring the underlying brain circuitry associated with important 
emotional and cognitive tasks. 
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